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FULLY AUTOMATED ENZYMATIC SYNTHESIS OF GLYCANS

by

JIABIN ZHANG

Under the Direction of Jun Yin, PhD

ABSTRACT
Oligosaccharides, together with oligonucleotides and oligopeptides, comprise the three major
classes of natural biopolymers. Automated systems for oligonucleotide and oligopeptide synthesis
have significantly advanced developments in biological science by allowing non-specialists to
rapidly and easily access these biopolymers. Researchers have endeavored for decades to develop
a comparable general automated system to synthesize oligosaccharides. Such a system would have
a revolutionary impact on the understanding of the roles of glycans in biological systems. The
main challenge to achieving automated synthesis is the lack of general synthetic methods for
routine synthesis of glycans. Currently, the two main methods to access homogeneous glycans and
glycoconjugates are chemical synthesis and enzymatic synthesis. Enzymatic glycosylation can
proceed stereo- and regiospecifically without protecting group manipulations. M oreover, the

reaction conditions of enzyme-catalyzed glycosylations are extremely mild when compared to
chemical glycosylations. Over the past few years, methodology towards the automated chemical
synthesis of oligosaccharides has been developed. Conversely, while automated enzymatic
synthesis is conceptually possible, it is not as well developed.
Inspired by the success of automated oligosaccharide synthesis through chemical glycosylation, a
fully machine-driven automated system is built up here for oligosaccharides synthesis through
enzymatic glycosylation in aqueous solution. The designed automation system is based on the use
of a thermosensitive polymer and a commercially available peptide synthesizer to fully achieve
automation process.
An automated platform for chemo-enzymatic glycopeptide synthesis is built up which easily
assembles glycopeptides in an organic phase solvent system before extending oligosaccharide
residues by enzymatic glycosylation. Our system is based on the use of an amine-functionalized
silica resin to facilitate the linkage of the primers needed to begin the chemical or enzymatic
synthesis of the target compounds to a solid support. Using our platform, a peptide from mucin 1
with different important glycan epitopes was successfully prepared with a resin transfer step by
hand.
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1
1.1
1.1.1

INTRODUCTION

Background
General Introduction to Glycans

Glycans are biopolymers which contain a large number of monosaccharides linked glycosidically.
Glycans also called glycoconjugates, include glycoproteins, glycolipids, proteoglycans, or
polysaccharides.1-3 Monosaccharides are the simple sugars with multiple OH groups, and can be a
triose, tetrose, pentose or hexose based on number of carbons. Hundreds of monosaccharides have
been found right now. However, only a few of them are commonly found and well-studied in living
organism. A universal symbol for the representation of glycans has been well developed in
glycoscience. M onosaccharide was presented by simple shapes, such as round, square, triangle,
diamond, fivepointed star and so on, with different standard colors including yellow, green, blue,
red, orange and purple (Figure 1.1).4
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Figure 1.1 Structures and symbols of common monosaccharides
1.1.2

Automated Platform for Biopolymer Synthesis

Reliable and rapid access to oligonucleotides and oligopeptides by commercial automated
synthesizers has fundamentally altered biological research. A major breakthrough in the synthesis
of oligonucleotides and oligopeptides was the use of solid-phase synthetic methodologies.5 This
development in synthetic chemistry enabled the subsequent use of automated synthesizers based
on the methodology.6 A number of automated platforms have been developed for automated
assembly of the natural biopolymers (oligosaccharides, oligonucleotides and oligopeptides), since
solid phase peptide synthesis was first reported by R. B. M errifield in 1963. 7-10 In 1982, the First
commercially available oligonucleotide synthesizer was developed by Biosearch of Novato.11 This
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platform was built up based on solid phase synthesis with a peptide synthesizer. In 1984, R.
B.M errifield won Nobel Prize in Chemistry because of his special contribution for solid phase
synthesis. Over the past few decades, many advanced automated synthesizers have been put into
market to produce almost every possible oligopeptides and oligonucleotides which greatly advance
the fields of biology and medicine.
First commercially available
oligonucleotide synthesizer
First Solid Phase
Synthesis for Oligopeptide

1963

1971

First Enzymatic
Oligosaccharide Synthesizer

Enzymatic Solid Phase
Synthesis for Oligosaccharide
1982

1984

1990s

2001

2018

NobelPrize in Chemistry
for Solid Phase Synthesis
First Solid Phase Synthesis
for Oligosaccharide

First Oligosaccharide
Synthesizer

Figure 1.2 Timeline of automated synthesis for bioplolymers
However, a general commercial system for the synthesis of oligosaccharides has yet to be
implemented, mainly due to the lack of general synthetic methods. With a goal of achieving
automated synthesis of complex oligosaccharides, many methodologies are currently being
developed by synthetic chemists to address the challenges in carbohydrate chemistry that have
prohibited automation. The use of solid-phase synthesis for the construction of oligosaccharides
was initiated with Frechet and co-workers in 1971.12 However, it was not until 2001 that Seeberger
and co-workers reported the first automated synthesis of oligosaccharides based on a solid-phase
synthetic method.13 The first automated glycan synthesizer was constructed by modifying a peptide
synthesizer, and the synthetic process closely resembles protocols established for the generation
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of peptides. To achieve automated synthesis, the first monosaccharide residue is attached through
its reducing end to a solid support via a linker. The linker must be cleavable to release the final
product upon the completion of the synthesis. Once the hydroxyl group to be modified in the
coupling reaction is exposed by selective deprotection, addition of a glycosyl donor and activator
will initiate the glycosylation reaction. Typically, the activator is a reagent that can generate a
leaving group at the anomeric position. Upon the completion of one reaction cycle, subsequent
sugar residues can be added by repeating the same overall process. The acquisition of final product
requires cleavage of the fully protected material from the solid support and removal of the
protecting group. One of the main advantages of the use of a solid-phase support in oligosaccharide
synthesis is that considerable excess of the glycosyl donor and other regents can be used to drive
the reaction to completion without the need to separate out the final product from these reagents.
Side products and other unwanted materials can be removed by a single wash while the desired
glycan remains covalently attached to the solid support.

Figure 1.3 The Principle of Solid Phase Synthesis
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1.1.3

Enzymatic Glycosylation

Enzymatic glycosylations are reactions which are catalyzed by glycotransferase to extend sugars
on the oligosaccharide chains.14 Sugar nucleotides, which are shown below (Figure 1.4), are used
as donors in these reactions.1 Enzymatic glycosylation is able to proceed stereo- and
regioselectively without the need to undergo tedious protecting group manipulations. Even for
very sterically demanding couplings such as those involving sialic acid, enzymatic glycosylation
can be performed selectively. Enzymatic reactions occur in aqueous solutions and only require
limited control over reaction conditions such as temperature, system pH, and the presence or
absence of metal ions. Also, there are no toxic byproducts of the glycosylation process, making
the enzymatic synthesis of oligosaccharides an environmental friendly approach.

Figure 1.4 Enzymatic synthesis of oligosaccharide
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Figure 1.5 Structures of Common Sugar Nucleotides
1.2

S ignificance
Automated synthesis of biopolymers could save researchers lots of time and energy by

using machine. The researchers just need to set up a well-defined program before making these
biopolymers and click start button to get the targeting molecules. In this case, non-experts could
synthesize complex structural long chain biopolymer. The peptide synthesizer, which has a long
history, shows a highly automated production process and was commercialized for a long time.
This work have built up an automated platform for glycan synthesis and will greatly promote the
area of chemical biology and pharmacy.
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FIRS T GENERATION AUTOMATED PLATFORM

Oligosaccharides, oligonucleotides, and oligopeptides comprise the three major classes of natural
biopolymers.15 Structurally defined glycans have many important biological and medical
applications. They find use in glycan microarray studies, 16 clinical diagnostics,17 enzymatic
activity tests,18 and the development of carbohydrate-based vaccines.3, 19 However, it is difficult to
obtain suitable quantities of homogeneous oligosaccharides from nature by extraction for
biological studies. Synthetic preparation by either chemical or enzymatic glycosylation is the only
way to obtain amounts of homogeneous oligosaccharides sufficient for research applications.
Chemical glycosylation can produce structurally defined glycans with diverse natural and
unnatural structures,20 while enzymatic glycosylation can produce both simple and complicated
glycans with high regio- and stereo-specificity under mild reaction conditions. 21 Regardless, both
chemical and enzymatic methods require skilled researchers to perform the operation, which is a
time-consuming and labor-intensive process.
The advent of automated systems for the synthesis of oligonucleotides and oligop eptides allows
non-specialists to rapidly produce these biopolymers and is responsible for greatly advancing the
fields of biology and medicine.22 Over the past few decades, researchers have put considerable
efforts into developing a comparable automated synthesizer to produce oligosaccharides. 12, 23-25 In
1999, Wong and co-workers developed a programmable one-pot solution-phase strategy for the
synthesis of oligosaccharides.26 In 2001, a landmark breakthrough from Seeberger and co-workers
opened the machine-driven synthesis of oligosaccharides based on solid-phase synthesis and
chemical glycosylation.13 This work adopted the same concept of solid-phase synthesis, which was
demonstrated by M errifield for peptide synthesis. 27 Subsequently, a large number of
oligosaccharides have been successfully prepared by applying this platform. 28-43 In addition, many
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other automated approaches towards chemical glycosylation were also developed to produce
oligosaccharides,44-46 such as an HPLC-based automated system, Yoshida’s electrolysis cell-based
automated system, and a Fluorous-tag solid phase system. Nevertheless, chemical glycosylations
suffer from tedious protection/deprotection manipulations. By comparison, enzymatic reactions
are advantageous in both efficiency and specificity. Although automated enzymatic synthesis is
conceptually possible, it is not as well developed. Herein, we report an automated system for the
preparation oligosaccharides (Figure 2.1). This system is based on enzymatic glycosylation, a
temperature-dependent polymer, and a commercially available peptide synthesizer to fully realize
the automation process.

Figure 2.1 Automated enzymatic synthesis of oligosaccharide.
The key steps for sugar elongation in the automation process are the reaction and separation steps.
Initially, we attempted to use M errifield’s concept on enzymatic glycosylation. Enzymatic
synthesis using solid-phase methodology was reported many years ago. However, we and many
other researchers found that, in general, enzymatic glycosylation on a solid-phase either does not
work well or gives inadequate yields. This is due to the incompatibility between enzymes and solid
resin. This problem could not be solved to a satisfactory degree even after we optimized several
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parameters such as altering the length of linkers, utilizing different resins, and varying the particle
size of the resins. At the same time, many works found that enzymatic glycosylations can be
performed on solution-phase resins/polymers. However, the use of solution-phase supports or
polymers increases the difficulty of product purification. In 2010, Nishimura and co-workers used
a globular protein-like PAM AM dendrimer for automated synthesis,47 which allows the product to
be separated by ultrafiltration. However, ultrafiltration is a difficult manipulation to be controlled
by a machine. In addition, significant product loss was also observed during the purification
process owing to the physical properties of hollow fiber-based material.
2.1

Resin

In 1963, the first solid phase synthesis was reported by by R. B. M errifield. Subsequently, a
number of automated synthesizers based on the solid phase synthesis were reported by many other
research groups and companies. These synthesizers have been used to prepare all types natural
biopolymers (peptide, nucleotides and saccharides). All the traditional solid phase resins which
have been used for automated synthesis have many holes.

Figure 2.2 Thermosensitive Polymer (PNIPAM ). LCST, Lower Critical Solution
Temperature.
In our design, Poly(N-isopropylacrylamide) (PNIPAM ),48 a temperature-dependent polymer, is
used as a support. When the environmental temperature decreases below that of the lower critical
solution temperature (LCST), PNIPAM can form intermolecular hydrogen bonds with water,
which allows it to be solubilized in aqueous solutions in which it can be accessed by
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glycosyltransferases. When the temperature rises, hydrogen bonds are formed intramolecularly,
which causes the aggregation and precipitation of PNIPAM (Figure 2.2). Consequently, a simple
filtration manipulation can separate the product from other reagents such as sugar nucleotides and
metal ions. The recovery yield of this polymer can reach more than 80% over ten cycles . M ore
importantly, temperature can easily be controlled on an instrument such as a peptide synthesizer.
2.2

Linker

Figure 2.3 Conjugation of Oligosaccharide Primer (lactose) with PNIPAM through a
Cleavable Linker.
A cleavable linker is required to conjugate an oligosaccharide primer with the PNIPAM polymer.
M ost known cleavable linkers require strong acidic or basic conditions during cleavage. However,
glycans are not stable under such conditions.46, 49 To avoid possible damage to the product, we
used a thioether linker in this work (Figure 2.3). The thioether bond is oxidized to a sulfone by
hydrogen peroxide. After hydrolysis, the oligosaccharide conjugate contains a terminal NH2 in an
aqueous solution. Compound 1 (lactose with aminopropyl linker) was conjugated with PNIPAM
polymer in the presence of thiodiglycolic anhydride, giving product 4 in 72% yield as confirmed
by NM R (Appendix A). Unreacted lactose primer can be removed through dialysis (M WCO:
1000). To test the cleavage efficiency of this linker, a standard peptide linked with lactose was
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treated with hydrogen peroxide (1M , pH 10). The results show that more than 80% of lactose can
be released in less than 2 hours (Figure 2.4). In addition, we also tested the enzymatic activity of
many glycotransferases with both 1 and 4. We found no significant difference between 1 and 4,
indicating that enzymatic glycosylation holds almost comparable activity on the acceptor whether
in solution or on soluble polymer.

Figure 2.4 Lactose Release from Thioether Linker Bound Peptide
2.3

Instrument

Finally, a CEM Liberty Blue peptide synthesizer was chosen to perform the designed automation
process as its functional units fit our strategy well. It has a reaction vessel connected with a filter
and a temperature-control system, which is controlled by a computer. The enzymes, nucleotide
sugars, and reaction buffers can be stored in the preexisting tubes in which amino acids would
normally be stored during peptide synthesis. Reagents are automatically injected into the reaction
vessel through a tubing system. (Figure 2.5).
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Figure 2.5 Peptide Synthesizer (CEM Liberty Blue) Used for Automation Synthesis in
This Work.
2.4

Automated Process

We chose compound 6 (oligosaccharides GM 1) as a target to test our system (Figure 2.6).
Ganglioside GM 1 is a glycan epitope located on the cell surface and plays important roles in many
biological processes such as virus-cell interactions.50 The enzymatic synthesis of GM 1 from
lactose involves three glycosylation steps. 50 The enzymes used are Pasteurella multocida α2,3sialyltransferase (PmsT1), Campylobacter jejuni β1,4-N-acetylgalactosaminyltransferase (CgtA)
and Campylobacter jejuni β1,3-galactosyltransferase CgtB.50 The standardized procedure contains
three processes (Figure 4B): automated synthesis, product release, and product purification. In
order to adapt the CEM peptide synthesizer for this purpose, several optimization procedures were
required. The program protocol was first optimized for enzymatic reactions (Figure 2.7). The
synthetic glycosylation materials including the NmCSS (CM P-sialic acid synthetase from
Neisseria meningitis), PmsT1, CgtA, CgtB, CTP, Neu5Ac, UDP-GalNAc, UDP-Gal, and reaction
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buffer were stored in the preexisting tubes. Compound 4, prepared as described above, was used
as the glycosylation primer. To the reaction vessel of the CEM Liberty Blue, 330 mg (50 umol) of
conjugated polymer (4) was loaded. The automated synthetic process was then started by
automatically injecting NmCSS, PmST1, CTP (3 equiv), Neu5Ac (3 equiv), and reaction buffer
(10 mL, pH 8.0). The reaction time and the amount of enzyme usage were calculated based on
enzyme kinetic parameters. Once the first reaction finished (3 h), the reaction solution temperature
was increased to 90 ℃ to precipitate the glycosylation product. Unreacted materials and by products were removed by filtration. The precipitate was washed and then CgtA, UDP-GalNAc (2
equiv), and reaction buffer (10 mL, pH 8.0) were injected into the reaction vessel to initiate the
second glycosylation step. Once this reaction finished (6 h), the glycosylation product was
precipitated out and washed as described above. CgtB, UDP-Gal (2 equiv), and reaction buffer (10
mL, pH 8.0) were injected to initiate the third glycosylation step. Once this step finished (6 h), the
product was precipitated and washed. The automation process was stopped at this point, and the
precipitate was taken out and dissolved in water. The target oligosaccharide GM 1 (Figure 5) was
released by the treatment of the polymer with hydrogen peroxide (1 M , pH 10). After HPLC
purification, 20 mg of GM 1 oligosaccharide was obtained in 38% yield from compound 4. The
product was confirmed by NM R and M S analysis (see general methods and Appendix A).
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Figure 2.6 The Principle of Automation Synthesis of GM 1

Figure 2.7 Automated Enzymatic Synthesis of Oligosaccharides Synthesis.
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2.5

Results

In a similar automated manner, oligosaccharides for Blood group O, A, and B were also
successfully prepared (Figure 2.8 and Table 2.1) using enzymes reported previously. 51 Blood
group O, A, and B Oligosaccharides were obtained in 27 to 38% yield (more than 10 mg scale,
Table 2.1). The product yields obtained by the automated system are only slightly lower than the
yields in in vitro synthesis. Nevertheless, the automated synthesis process can save reaction time
and labor to a great extent. The products were confirmed by NM R and M S analysis (see general
methods and Appendix A). In addition to preparing these important oligosaccharide structures, we
also tested our automation system by synthesizing Poly-N-acetyllactosamine (poly-LacNAc).
Poly-LacNAc contains Galβ1,4GlcNAc repeating units, and has been identified as an important
ligand for galectin-mediated cell adhesion to extra-cellular matrix (ECM ) proteins. Recently, it
was also found Poly-LacNAc can serve as an age-specific ligand for rotavirus P[11] in neonates
and infants.52 The in vitro enzymatic synthesis of Poly-LacNAc involves two glycosylation
reactions catalyzed by LgtA and LgtB. 53 Since LgtA prefers a substrate with a longer chain,
trisaccharide GlcNAc

1,3Gal 1,4Glc with aminopropyl linker was conjugated with

PNIPAM to serve as a primer. In a similar program and automated manner as mentioned above,
18 reaction cycles (each glycosylation reaction step was performed two times to get high
conversion) were performed in seven days to produce Poly -LacNAc with 12 residues in 9% yield
(8 mg). Although more glycosylation reaction steps can be performed to produce longer chain,
purification is unsuccessful as the product has poor solubility in water when the sugar chain has
more than 12 monosaccharide residues.
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Figure 2.8 Oligosaccharides That Were Used to the Test Automated System in This
Work.
Table 2.1 Oligosaccharides That Prepared by Automation System

a

Product

Enzymes

E/Na (mg)

6

PmsT1, CgtA, CgtB

1.6

2.1

7

LgtB, FucT

1.0

2.5

8

LgtB, FucT, BgtA

1.0

2.5

9

LgtB, FucT, GTB

1.0

2.5

10

LgtA, LgtB

1.7

1.0

Yield (%)

Time (hours)

Product (mg)

38

27

20

35

24

13

1.9

29

36

14

1.8

27

36

13

9

168

8

1.8

enzyme usage

2.6
2.6.1

Materials and General Methods
Materials

All commercially available solvents and reagents were used without purification. PNIPAM
dendrimer (M n5500) was purchased from Sigma Aldrich Inc (USA). Thiodiglycolic anhydride
was purchased from Fisher. N-Acetylneuraminic acid (Neu5Ac) and cytidine 5'-triphosphate (CTP)
were purchased from Carbosynth Limited. Sugar nucleotides uridine 5’-diphospho-galactose
(UDP-Gal),54 UDP-N-acetylglucosamine (UDP-GlcNAc),55 UDP-N-acetylgalactosamine (UDPGalNAc),55 and guanosine 5’-diphospho-L-fucose (GDP-Fuc)55 were prepared as described
previously. Helicobacter pylori β1,3-N-acetylglucosaminyltransferase (HpLgtA),56 Neisseria
meningitides β1,4-galactosyltransferase (NmLgtB),56 Neisseria meningitidis CM P-sialic acid
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synthetase (NmCSS),57 Pasteurella multocida multifunctional α2,3-sialyltransferase 1 M 144D
mutant (PmST1 M 144D),58 Campylobacter jejuni β1,4-N-acetyl-galactosaminyltransferase
(CgtA),50 Campylobacter jejuni β1,3-galactosyltransferase mutant (CgtB), Helicobacter mustelae
α1,2

-fucosyltransferase,

Helicobacter

mustelae

α1,3-N-acetyl-galactosaminyltransferase

(BgtA),and human blood group B glycosyltransferase (GTB) were expressed and purified as
described previously.
1

H-NM R and 13 C-NMR spectra were recorded by using a Bruker 400 spectrometer (400 M Hz for

1

H, 100 M Hz for 13 C) or a Bruker 600 spectrometer (600 M Hz for 1 H, 150 M Hz for 13 C). All 1H

Chemical shifts (in ppm) were assigned in reference to CDCl3 (δ= 7.24 ppm), M eOD (δ= 4.87
ppm), and D2O (δ = 4.79 ppm) and all 13C NM R spectra were calibrated with CDCl3 (δ = 77.00
ppm). HPLC was performed with a Shimadzu Prominence UFLC. Column: Waters XBridge BEH
amide column, 130 Å, 5 μm, 4.6 mm × 250 mm. A semi-preparative Waters XBridge BEH amide
column (130 Å, 5 μm, 10 mm × 250 mm) was used for purification. Solvent A: 100 mM ammonium
formate, pH 3.2. Solvent B: Acetonitrile. Semi-preparative Agilent Eclipse XDB-C18, 5 μm, 9.4
× 250 mm. Aeris PEPTIDE 3.6 µm CB-C18, 4.6 mm x 250 mm. Solvent A: 0.1% TFA Water.
Solvent B: 0.1% Acetonitrile. High-resolution electrospray ionization mass spectrometry (ESIHRM S) experiment was performed on an LTQ-Orbitrap Elite mass spectrometer (Thermo Fisher).
Automated synthesis was performed on a Liberty Blue peptide synthesizer (Figure 2.5, CEM)
according to the basic manufacture’s manual and software for controlling operation with a
designated program (Figure 2.7) and sequence for the synthesis of the present target compounds.
2.6.2

Methods

Scheme 1
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Compound 4 was prepared from PNIPAM . In detail, PNIPAM (550 mg, 0.1 mmol) was dissolved
in DM F (10 ml). Thiodiglycolic anhydride (132 mg, 1 mmol) and DM AP (122 mg, 1 mmol) were
added to the solution, and the reaction mixture was stirred at room temperature overnight. After
the reaction completed the solvent was removed by high vacuo and the product purified by dialysis
(M WCO 1000) to obtain compound 3. Compound 3 and compound 1 (80 mg, 0.2 mmol) were
dissolved in DM F (10 ml). PyAOP (522 mg, 1 mmol) and DIPEA (129 mg, 1 mmol) were added
to the solution, and the reaction mixture was stirred at room temperature overnight. The solvent
was removed by high vacuo and the product purified by dialysis (M WCO 1000) to obtain
compound 4. Compound 12 was prepared from PNIPAM and compound 11 using the protocol as
described for the synthesis of compound 4. The sugar loading efficiency is in the range of 72%
(Appendix A).

Scheme 2
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Compound 13 was prepared with the peptide synthesizer in 4 cy cles. In detail, resin (333 mg, 0.25
mmol) was added to the reaction vessel and all the required reagents were loaded into the tubes.
The following procedures were performed by the program on the automated synthesizer. The resin
was swelled for 300 s with DM F (10 ml). For the first coupling cycle, 5 ml piperidine in the DMF
(v/v=20%) was added to the reaction vessel and the mixture was keep at 50 ℃ for 2 min to
deprotect the Fmoc group. The operation was repeated to ensure complete deprotection. Then the
resin was washed with DM F (3×5 ml). Tyr solution (5 ml), DIPEA (2 ml), HBTU (2 ml) were
added to the reaction vessel to form a solution (9 ml) as below: (0.25 mmol resin, 1 mmol Tyr, 1
mmol DIPEA and 1 mmol HBTU). The mixture was kept at 50 ℃ for 10 min. This operation was
repeated. After 4 cycles, the peptide bound resin was transferred to a tube and 4 ml cleavage
cocktail (TFA:H2O:TIS:DODT=92.5:2.5:2.5:2.5) was added to the tube to give a crude p roduct.
The final product was purified by HPLC (acetonitrile, 15%-70%, 40min). 1 H-NM R (400 MHz,
M eOD), δ 7.051-6.648 (m, 16H), 4.548-4.442 (m, 3H), 3.926 (dd, J1 = 4.8 Hz, J2 = 8.4 Hz 1H),
3.083-2.700 (m, 8H).
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C NM R (101 M Hz, M eOD) δ 174.27, 171.60, 171.45, 168.30, 156.86,

155.96, 155.90, 130.24, 130.06, 130.03, 129.89, 127.52, 127.38, 127.32, 124.54, 115.49, 114.90,
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114.86, 55.09, 54.56, 54.26, 36.74, 36.65, 36.43. HRM S (ESI): m/z [M +H] +calcd for
C36H39N5O8 670.2872; found: 670.2829.
Compound 14 was prepared from compound 13. In detail, compound 13 (67 mg, 0.1 mmol) was
dissolved in DM F (2 ml). Thiodiglycolic anhydride (66 mg, 0.5 mmol) and DM AP (61 mg, 0.5
mmol) were added to the solution and the reaction mixture was stirred at room temperature
overnight. The solvent was removed by high vacuo, and the product was purified by HPLC
(acetonitrile, 15%-70%, 30min) to get compound 14 (43 mg) in 53.6% yield regarding compound
13. 1 H-NM R (400 M Hz, MeOD), 7.04-6.64 (m, 16H), 4.46-4.40 (m, 4H),3.32-2.68 (m, 12H). 13C
NM R (101 M Hz, M eOD) δ 173.07, 171.11, 170.78, 170.70, 170.26, 169.04, 154.35, 154.27,
128.48, 128.46, 128.40, 126.20, 125.88, 125.87, 125.76, 113.41, 113.36, 54.04, 53.90, 53.68, 53.22,
34.96, 34.86, 34.76, 34.71, 33.43, 32.03. HRM S (ESI): m/z [M +H]+calcd for C40H43N5O11S
802.2753; found: 802.2744.
Compound 15 was prepared from compound 14. In detail, compound 14 (40 mg, 0.05 mmol) and
compound 1 (60 mg, 0.15 mmol) were dissolved in DM F (10 ml). PyAOP (261 mg, 0.5 mmol)
and DIPEA (65 mg, 0.5 mmol) were added to the solution, and the reaction mixture was stirred at
room temperature overnight. The solvent was removed by high vacuo, and the product was purified
by HPLC (acetonitrile, 3%-40%, 30min) to get compound 15 (21 mg) in 35.5% yield regarding
compound 14. 1 H-NM R (400 M Hz, MeOD), δ 7.964-6.835 (m, 8H), 6.610-6.562 (m, 8H), 4.3804.326 (m, 4H), 4.265-4.246 (d, J = 7.6 Hz, 1H), 4.204-4.185 (d, J = 7.6 Hz, 1H), 3.823-3.317 (m,
12H), 3.208-3.125 (m, 6H), 2.970-2.591 (m, 10H), 1.695-1.665 (m, 2H). HRM S (ESI): m/z [M
+H]+ calcd for C55H70N6O21S 1183.4388; found: 1183.4331.
Sugar release efficiency was determined using compound 15. In detail, 1 mg of compound 15 was
dissolved in 1 M H 2 O2 solution at pH=10. The release efficiency was monitored by HPLC
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(acetonitrile, 3%-90%, 40min) at time point intervals of 1h, 2h, 4h, and 12h. M ore than 80% sugar
was released from compound 15 (Figure 2.4). All reactions were run in triplicate.
Enzyme activity test. The enzyme activity for the sugar bound PNIPAM was tested with PmST1.
In detail, a reaction mixture with a final volume of 100 µl containing 50 mM Tris-HCl, 1mM of
Lactose β-pNP, 10 mM of Neu5Ac, 10 mM of CTP, 5 mM of M g2+, 1×10-3 units of NmCSS,
1×10-4, 2×10-4, 3×10-4, 4×10-4, and 5×10-4 units of PmST1 was incubated at 25°C for 30 min.
The reaction was quenched by adding an equal volume of ethanol and freezing at -80 °C for 30
min. The reaction was monitored by an analytical GL Science Inertsil ODS-4 column (100 Å, 5
μm, 4.6 mm × 250 mm) with UV detector (260 nm). The running solvents were solvent A (H2O
with 0.1% TFA) and solvent B (acetonitrile with 0.1% TFA). The running condition was a gradient
elution with solvent B linear increased from 5% to 10% within 25 min, with a total flow rate of 1
mL/min. All reactions were run in triplicate. The reactivity of sugar bound PNIPAM was tested
with Lactose-PNIPAM (compound 4) using the same conditions. The reaction was monitored by
Aeris PEPTIDE 3.6 µm CB-C18, 4.6 mm x 250 mm with UV detector (210 nm). The running
solvents were solvent A (H2O with 0.1% TFA) and solvent B (acetonitrile with 0.1% TFA). The
running condition was gradient elution with solvent B being held at 20% for 5 min, then increasing
linearly to 45% over 2 min, then holding at 45% for 5 mins, then increasing linearly to 60% over
2 min, then holding at 60% for 2 mins, then increasing linearly to 80% over 2 min, then holding at
80% for 13 mins with a total flow rate of 1 mL/min.
Time optimization was performed with the same substrate Lactose-pNP and Lactose-PNIPAM
(compound 4). In detail, a reaction mixture in a final volume of 100 µl containing 50 mM TrisHCl, 1mM of Lactose-pNP, 10 mM of Neu5Ac, 10 mM of CTP, 5 mM of M g2+, 1×10-3 units
NmCSS, and 3×10-4 units of PmST1 was incubated at 25°C for 30 min (1 h, 2 h, 3 h and 6 h). The
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reaction was quenched by adding an equal volume of ethanol and freezing at -80 °C for 30 min.
The reaction was monitored by an analytical GL Science Inertsil ODS-4 column (100 Å, 5 μm, 4.6
mm × 250 mm) with UV detector (260 nm). The running solvents were solvent A (H2O with 0.1%
TFA) and solvent B (acetonitrile with 0.1% TFA). The running condition was gradient elution
with solvent B linearly increasing from 5% to 10% over 25 mins, with a total flow rate of 1 mL/min.
All reactions were run in triplicate. The reactivity of sugar bound PNIPAM was tested by LactosePNIPAM (compound 4) with the same conditions. The reaction was monitored by Aeris PEPTIDE
3.6 µm CB-C18, 4.6 mm x 250 mm with UV detector (210 nm). The running solvents were solvent
A (H2O with 0.1% TFA) and solvent B (acetonitrile with 0.1% TFA). The running condition was
gradient elution with solvent B at 20% for 5 min, then increasing linearly to 45% over 2 min, then
holding at B 45% for 5 mins, then increasing linearly to 60% over 2 min, then holding at 60% for
2 mins, then increasing linearly to 80% over 2 min, then holding at 80% for 13 mins with a total
flow rate of 1 mL/min.
Scheme 3

23

Compound 17 was prepared from compound 16 by using NmCSS and PmST1. In detail, a reaction
mixture with a final volume of 10 ml containing 50 mM Tris-HCl, 42.5 mg of 10 (0.1 mmol), 15
mM of Neu5Ac, 15 mM of CTP, 5 mM of M g2+, 7.4 mg of NmCSS, and 1.6 mg of PmST1 was
incubated at 25°C to allow the formation of compound 17. After 3 hours, the reaction was
monitored by TLC (EtOAc/M eOH/H2O/HOAc=5:2:1.4:0.4). An equal volume of ethanol was
added to remove proteins and the solution was concentrated in vacuo. After purification by BioGel P-2 column 60 mg of compound 17 was obtained in 83.8% yield regarding compound 16. 1 HNM R (400 M Hz, D2O), δ 4.44 (d, J = 8.0 Hz, 1H), 4.39 (d, J = 8 Hz, 1H), 4.03 (dd, J1 = 2.8 Hz,
J2 = 6 Hz 1H), 3.92-3.45 (m, 19H), 3.37 (t, J = 6.6 Hz, 2H), 3.23 (t, J = 4.4 Hz 1H), 2.68 (dd, J1
= 4.4 Hz, J2 = 12.4 Hz, 1H), 1.93 (s, 3H), 1.84 (m, 2H), 1.73 (t, J = 12.4, 1H). 13 C NM R (100 MHz,
D2O), δ 174.97, 173.86, 102.60, 102.10, 99.75, 78.18, 75.43, 75.13, 74.73, 74.30, 72.83, 72.76,
71.73, 69.32, 68.32, 68.04, 67.41, 67.32, 62.52, 60.98, 59.99, 51.63, 47.82, 39.58, 28.18, 21.99.
HRM S (ESI): m/z [M +Na]+ calcd for C26H44N4O19 739.2492; found: 739.2434.
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Compound 18 was prepared from compound 17 by using CgtA. In detail, a reaction mixture with
a final volume of 8.4 ml containing 50 mM Tris-HCl, 10 mM trisaccharide (60mg), 15 mM of
UDP-GalNAc, 5 mM of M g2+, and 2.1 mg of CgtA was incubated at 25°C to allow the formation
of

tetrasaccharide.

After

6

hours,

the

reaction

was

monitored

by

TLC

(EtOAc/M eOH/H2O/HOAc=5:2:1.4:0.4). An equal volume of ethanol was added to remove
proteins and the solution was concentrated in vacuo. After purification by using Bio-Gel P-2
column. 52 mg of compound 18 was obtained in 67.5% yield regarding compound 17. 1 H-NMR
(400 M Hz, D2O), δ 4.74 (d, J = 8.8 Hz, 1H), 4.53 (d, J = 8.0 Hz, 1H), 4.49 (d, J = 8 Hz, 1H), 4.16
(m, 2H), 4.02-3.57 (m, 22H), 3.48-3.27 (m, 5H), 2.68 (dd, J1 = 4.4 Hz, J2 = 12.4 Hz, 1H), 2.02
(m, 6H), 1.95 (m, 3H).
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C NM R (100 M Hz, D2O), δ 174.97, 174.79, 174.05, 102.71, 102.54,

102.06, 101.58, 78.53, 77.11, 74.69, 74.32, 74.26, 73.96, 73.01, 72.68, 72.23, 71.21, 69.96, 68.66,
67.95, 67.72, 67.31, 62.78, 61.11, 60.49, 60.04, 52.28, 51.53, 48.06, 47.82, 36.87, 28.18, 22.55,
21.99. HRM S (ESI): m/z [M +Na]+ calcd for C34H57N5O24 942.3285; found: 942.3248.
Compound 19 was prepared from compound 18 by using CgtB. In detail, a reaction mixture with
a final volume of 5.6 ml containing 50 mM Tris-HCl, 10 mM tetrasaccharide (52mg), 15 mM of
UDP-Gal, 5 mM of M g2+, and 1.8 mg of CgtB was incubated at 25°C to allow the formation of
compound

19.

After

6

hours,

the

reaction

was

monitored

by

TLC

(EtOAc/M eOH/H2O/HOAc=5:2:1.4:0.4). An equal volume of ethanol was added to remove
proteins and the solution was concentrated in vacuo. 48 mg of compound 19 was obtained in 79%
yield regarding compound 18. 1 H-NM R (400 M Hz, D2O), δ 4.67 (d, J = 8.8 Hz, 1H), 4.43 (m, 3H),
4.04 (m, 3H), 3.94 (m, 3H), 3.79-3.32 (m, 27H), 3.26-3.16 (m, 2H), 2.56 (m, 1H), 1.91-1.77 (m,
9H). 13 C NM R (151 M Hz, D2O) δ 175.02, 174.76, 174.11, 104.73, 102.58, 102.49, 102.10, 101.63,
80.31, 78.60, 77.13, 74.87, 74.73, 74.37, 74.34, 74.32, 74.05, 73.07, 72.72, 72.48, 72.25, 70.67,

25

70.00, 68.70, 68.57, 68.00, 67.89, 67.35, 62.81, 61.08, 60.92, 60.59, 60.09, 51.58, 51.17, 48.11,
47.87, 36.92, 28.22, 22.57, 22.03. HRM S (ESI): m/z [M +Na]+ calcd for C40H67N5O29
1104.3814; found: 1104.3766.

Scheme 4

Compound 22 was prepared from compound 21 using LgtA. In detail, a reaction mixture in a final
volume of 2 ml mixture containing 50 mM Tris-HCl (pH 8.0), 15.8 mg of compound 21 (10 mM ),
5 mM of M g2+, 15 mM of UDP-GlcNAc, and 0.6 mg of LgtA was incubated at 25°C to allow the
formation of compound 22. After 12 hours, the reaction was monitored by TLC
(EtOAc/M eOH/H2O/HOAc=5:2:1.4:0.4). An equal volume of ethanol was added to remove
proteins and the solution was concentrated in vacuo. The product was purified by using Bio-Gel
P-2 column. 13 mg of compound 22 was obtained in 65.5 % isolated yield regarding 21. 1 H-NMR
(400 M Hz, D2O), δ 4.70 (m, 2H), 4.49 (m, 3H), 4.15 (d, J = 2.8 Hz, 1H), 3.99-3.44 (m, 31H), 3.32
(m, 1H), 2.03 (s, 6H), 1.94 (m, 2H). 13 C NM R (101 M Hz, D2O) δ 174.90, 102.82, 102.71, 102.05,
81.94, 78.23, 78.05, 75.58, 74.81, 74.71, 74.48, 74.28, 73.48, 72.71, 72.10, 69.91, 69.59, 68.26,
67.30, 60.89, 60.38, 59.96, 59.76, 55.58, 55.07, 47.78, 28.16, 22.08. HRM S (ESI): m/z [M +H]+
calcd for C37H63N5O26 994.3834; found: 994.3757.
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Scheme 5

Compound 23 was prepared from compound 21 using FucT from Helicobacter mustelae. In detail,
a reaction mixture in a final volume of 4 ml mixture containing 50 mM Tris -HCl (pH 8.0), 31.6
mg of compound 21 (10 mM ), 5 mM of M g2+, 15 mM of GDP-Fucose, and 2.5 mg of 1,2-FucT
was incubated at 25°C to allow the formation of compound 23. After 6 hours, the reaction was
monitored by TLC (EtOAc/M eOH/H2O/HOAc=5:2:1.4:0.4). An equal volume of ethanol was
added to remove proteins and the solution was concentrated in vacuo. The product was purified by
using Bio-Gel P-2 column. 32 mg of compound 23 was obtained in 85.5 % isolated yield regarding
compound 21. 1 H-NM R (400 M Hz, D2O), δ 5.29 (d, J = 2.4 Hz, 1H), 4.69 (d, J = 8.4 Hz, 1H),
4.54 (d, J = 7.6 Hz, 1H), 4.48 (d, J = 8 Hz, 1H), 4.43 (d, J = 8 Hz, 1H), 4.22 (dd, J1 = 6.4 Hz, J2 =
13.2 Hz, 1H), 4.13 (d, J = 3.2 Hz, 1H), 4.01-3.54 (m, 26H), 3.46 (t, J = 6.4 Hz, 3H), 3.31 (m, 1H),
2.02 (s, 3H), 1.92 (m, 2H), 1.21 (d, J = 6.4 Hz, 3H). 13 C NM R (101 M Hz, D2O) δ 174.88, 102.86,
102.73, 102.05, 100.17, 99.35, 81.92, 78.24, 76.35, 75.75, 75.19, 75.03, 74.79, 74.71, 74.28, 73.46,
72.73, 72.00, 71.60, 69.92, 69.54, 69.06, 68.26, 68.12, 67.30, 66.88, 61.07, 60.86, 59.97, 59.92,
55.31, 47.79, 28.17, 22.14, 15.26. HRM S (ESI): m/z [M +Na]+ calcd for C35H60N4O25 959.3439;
found: 959.3450.

Scheme 6
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Compound 24 was prepared from compound 23 using BgtA. In detail, a reaction mixture in a final
volume of 1.5 ml mixture containing 50 mM Tris-HCl (pH 8.0), 14 mg of compound 23 (10 mM ),
5 mM of M g2+, 15 mM of UDP-GalNAc, and 0.6 mg of BgtA was incubated at 25°C to allow the
formation of compound 24. After 6 hours, the reaction was monitored by TLC
(EtOAc/M eOH/H2O/HOAc=5:2:1.4:0.4). An equal volume of ethanol was added to remove
proteins and the solution was concentrated in vacuo. The product was purified by using HPLC
(water/acetonitrile,75-35, 16min/35min). 10.2 mg of compound 24 was obtained in 59.9 % isolated
yield regarding compound 23. 1 H-NM R (600 M Hz, D2O), δ 5.23 (d, J = 2.4 Hz, 1H), 5.06 (d, J =
2.8 Hz, 1H), 4.58 (d, J = 5.6 Hz, 1H), 4.49 (d, J = 5.2 Hz, 1H), 4.37 (d, J = 5.2 Hz, 1H), 4.33 (d, J
= 5.6 Hz, 1H), 4.20 (dd, J1 = 4 Hz, J2 = 8.8 Hz, 1H), 4.12 (m, 3H), 4.02 (d, J = 2.4 Hz, 1H ), 3.873.51 (m, 29H), 3.35(m, 3H), 3.20 (m, 1H), 1.92 (s, 3H), 1.91 (s, 3H), 1.81 (m, 2H), 1.13 (d, J = 4.4
Hz, 3H), 13 C NM R (151 M Hz, D2O) δ 174.86, 174.73, 102.86, 102.75, 102.06, 99.99, 98.57, 91.25,
81.94, 78.23, 75.86, 75.62, 75.12, 75.08, 74.80, 74.72, 74.29, 72.76, 72.32, 72.08, 71.63, 71.03,
69.95, 69.89, 68.43, 68.26, 67.69, 67.60, 67.30, 66.83, 62.99, 61.26, 61.15, 60.87, 59.97, 59.88,
55.40, 49.45, 47.81, 28.18, 22.19, 21.92, 15.13. HRM S (ESI): m/z [M +Na] + calcd for
C43H73N5O30 1162.4232; found: 1162.4176.

Scheme 7
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Compound 25 was prepared from compound 23 using GTB from humans. In detail, a reaction
mixture in a final volume of 1.5 ml mixture containing 50 mM Tris -HCl (pH 8.0), 14 mg of
compound 23 (10 mM ), 5 mM of M g2+, 15 mM of UDP-Gal, and 0.6 mg of GTB was incubated
at 25°C to allow the formation of compound 25. After 6 hours, the reaction was monitored by TLC
(EtOAc/M eOH/H2O/HOAc=5:2:1.4:0.4). An equal volume of ethanol was added to remove
proteins and the solution was concentrated in vacuo. The product was purified by using HPLC
(water/acetonitrile,75-35, 18min/35min). 9.6 mg of compound 25 was obtained in 58.4 % isolated
yield regarding compound 23. 1 H-NM R (600 M Hz, D2O), δ 5.29 (d, J = 2.8 Hz, 1H), 5.21 (d, J =
1.6 Hz, 1H), 4.67 (d, J = 5.6 Hz, 1H), 4.59 (d, J = 5.2 Hz, 1H), 4.45 (d, J = 5.2 Hz, 1H), 4.41 (d, J
= 5.2 Hz, 1H), 4.27 (m, 2H), 4.17 (t, J = 4 Hz, 1H), 4.11 (d, J = 2.4 Hz, 1H ), 3.98-3.53 (m, 31H),
3.43 (m, 3H), 3.29 (m, 1H), 2.00 (s, 3H), 1.88 (m, 2H), 1.20 (d, J = 4.4 Hz, 3H),
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C NM R (151

M Hz, D2O) δ 174.88, 102.87, 102.77, 102.07, 100.05, 98.74, 92.96, 81.97, 78.25, 76.11, 75.84,
75.07, 74.91, 74.82, 74.73, 74.31, 72.78, 72.48, 72.10, 71.64, 71.10, 69.97, 69.45, 69.23, 68.27,
68.01, 67.65, 67.32, 66.79, 63.44, 62.44, 61.23, 61.13, 60.89, 59.99, 59.89, 55.39, 47.83, 28.20,
22.21, 15.15. HRM S (ESI): m/z [M +Na]+ calcd for C41H70N4O30 1121.3967; found: 1121.3912.

Scheme 8
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Fully automated enzymatic synthesis of GM 1 on our automated synthesizer. A synthetic program
was made for compound 6 that contains three cycles (table 2.1). Compound 4 was loaded into the
reaction vessel and all the enzymes and sugar nucleotide solutions added to the corresponding
tubes. The following procedures were performed by the program on the automated synthesizer.
For the first glycosylation, steps 1 and 2: Neu5Ac, CTP, M g2+ (5 ml) in 100 mM Tris-HCl (pH
8.0) and NmCSS, PmST1 (5 ml) were added to the reaction vessel to form a solution (10 ml) as
below: 15 mM Neu5Ac and CTP, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 7.4 mg of NmCSS, 1.6
mg of PmST1, and 5 mM compound 4; step 3: the temperature of the reaction mixture was
maintained at 25°C under 10 W of microwave irradiation. Glycosyl reaction was done at 25°C for
3 h (microwave 10 W, hold 3 h at 25°C, bubble on for 5 s, off for 600 s. This is a special case and
all the other glycosyl reactions were kept for 6 h); step 4: The temperature of the reaction mixture
was quickly brought up to 90°C under 50 W of microwave irradiation. It was kept at 90°C for 10
min and drained to push out all the waste to leave resin-bound sugar only (microwave 50 W, hold
10 min at 90°C, bubble on for 1 s, off for 3 s, drain for 100 s). This glycosylation was only done
by once and all the others were done by twice to improve the yield. For the second glycosylation,
steps 1 and 2: UDP-GalNAc, M g2+ (5 ml) in 100 mM Tris-HCl (pH 8.0), and CgtA (5 ml) were
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added to the reaction vessel to form a solution (10 ml) as below: 10 mM UDP-GalNAc, 50 mM
Tris-HCl (pH 8.0), 5 mM M g2+, 2.1 mg of CgtA, and 5 mM resin-bound sugar; step 3: the
temperature of the reaction mixture was maintained at 25°C under 10 W of microwave irradiation.
Glycosyl reaction was done at 25°C for 6 h (microwave 10 W, hold 6 h at 25°C, bubble on for 5
s, off for 600 s); step 4: The temperature of the reaction mixture was quickly brought up to 90°C
under 50 W of microwave irradiation. It was kept at 90°C for 10 min and drained to push out all
the waste to leave resin-bound sugar only (microwave 50 W, hold 10 min at 90°C, bubble on for
1 s, off for 3 s, drain for 100 s); steps 5 and 6: UDP-GalNAc, M g2+ (5 ml) in 100 mM Tris-HCl
(pH 8.0), and CgtA (5 ml) were added to the reaction vessel to form a solution (10 ml) as below:
10 mM UDP-GalNAc, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 2.1 mg of CgtA, and 5 mM resinbound sugar; step 7: the temperature of the reaction mixture was maintained at 25°C under 10 W
of microwave irradiation. Glycosyl reaction was done at 25°C for 6 h (microwave 10 W, hold 6 h
at 25°C, bubble on for 5 s, off for 600 s); step 8: The temperature of the reaction mixture was
quickly brought up to 90°C under 50 W of microwave irradiation. It was kept at 90°C for 10 min
and drained to push out all the waste to leave resin-bound sugar only (microwave 50 W, hold 10
min at 90°C, bubble on for 1 s, off for 3 s, drain for 100 s). For the third glycosylation, steps 1 and
2: UDP-Gal, M g2+ (5 ml) in 100 mM Tris-HCl (pH 8.0) and CgtB (5 ml) were added to the reaction
vessel to form a solution (10 ml) as below: 10 mM UDP-Gal, 50 mM Tris-HCl (pH 8.0), 5 mM
M g2+, 1.8 mg of CgtB, and 5 mM resin-bound sugar; step 3: the temperature of the reaction mixture
was maintained at 25°C under 10 W of microwave irradiation. Glycosyl reaction was done at 25°C
for 6 h (microwave 10 W, hold 6 h at 25°C, bubble on for 5 s, off for 600 s); step 4: The temperature
of the reaction mixture was quickly brought up to 90°C under 50 W of microwave irradiation. It
was kept at 90°C for 10 min and drained to push out all the waste to leave resin-bound sugar only
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(microwave 50 W, hold 10 min at 90°C, bubble on for 1 s, off for 3 s, drain for 100 s); steps 5 and
6: UDP-Gal, M g2+ (5 ml) in 100 mM Tris-HCl (pH 8.0) and CgtB (5 ml) were added to the reaction
vessel to form a solution (10 ml) as below: 10 mM UDP-Gal, 50 mM Tris-HCl (pH 8.0), 5 mM
M g2+, 1.8 mg of CgtB, and 5 mM resin-bound sugar; step 7: the temperature of the reaction mixture
was maintained at 25°C under 10 W of microwave irradiation. Glycosyl reaction was done at 25°C
for 6 h (microwave 10 W, hold 6 h at 25°C, bubble on for 5 s, off for 600 s); step 8: The temperature
of the reaction mixture was quickly brought up to 90°C under 50 W of microwave irradiation. It
was kept at 90°C for 10 min and drained to push out all the waste to leave resin-bound sugar only
(microwave 50 W, hold 10 min at 90°C, bubble on for 1 s, off for 3 s, drain for 100 s). After three
cycles, the resin-bound sugar was transferred to a flask and the sugar released under 1 M H2O2
(PH=10). The final compound 6 (20 mg) was purified by HPLC (water/acetonitrile,80-54.2,
35min/45min) in 38% yield from compound 4. 1 H-NM R (400 M Hz, D2O), δ 4.48 (m, 3H), 4.09
(m, 3H), 3.98 (m, 3H), 3.85 (d, J = 2 Hz, 1H), 3.81-3.52 (m, 22H), 3.46 (m, 2H), 3.30 (m, 3H),
3.10 (t, J = 4.4 Hz, 1H), 2.60 (dd, J1 = 3.2 Hz, J2 = 8.8 Hz, 1H), 1.97-1.78 (m, 9H). HRM S (ESI):
m/z [M +H]+ calcd for C40H69N3O29 1056.4090; found: 1056.4045.

Scheme 9

Fully automated enzymatic synthesis of Blood O on our automated synthesizer. A synthetic
program was made for synthesizing compound 7 and this program contains two cycles (table 2.1).
Compound 12 was loaded into the reaction vessel and all the enzyme and sugar nucleotide
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solutions were added to the corresponding tubes. The following procedures were performed by the
program on the automated synthesizer. For the first glycosylation, steps 1 and 2: UDP-Gal, M g2+
(5 ml) in 100 mM Tris-HCl (pH 8.0) and LgtB (5 ml) were added to the reaction vessel to form a
solution (10 ml) as below: 10 mM UDP-Gal, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 1.0 mg of
LgtB, and 4 mM compound 12; step 3: the temperature of the reaction mixture was maintained at
25°C under 10 W of microwave irradiation. Glycosyl reaction was done at 25°C for 6 h
(microwave 10 W, hold 6 h at 25°C, bubble on for 5 s, off for 600 s); step 4: The temperature of
the reaction mixture was quickly brought up to 90°C under 50 W of microwave irradiation. It was
kept at 90°C for 10 min and drained to push out all the waste to leave resin-bound sugar only
(microwave 50 W, hold 10 min at 90°C, bubble on for 1 s, off for 3 s, drain for 100 s); steps 5 and
6: UDP-Gal, M g2+ (5 ml) in 100 mM Tris-HCl (pH 8.0) and LgtB (5 ml) were added to the reaction
vessel to form a solution (10 ml) as below: 10 mM UDP-Gal, 50 mM Tris-HCl (pH 8.0), 5 mM
M g2+, 1.0 mg of LgtB, and 4 mM resin-bound sugar; step 7: the temperature of the reaction mixture
was maintained at 25°C under 10 W of microwave irradiation. Glycosyl reaction was done at 25°C
for 6 h (microwave 10 W, hold 6 h at 25°C, bubble on for 5 s, off for 600 s); step 8: The temperature
of the reaction mixture was quickly brought up to 90°C under 50 W of microwave irradiation. It
was kept at 90°C for 10 min and drained to push out all the waste to leave resin-bound sugar only
(microwave 50 W, hold 10 min at 90°C, bubble on for 1 s, off for 3 s, drain for 100 s). For the
second glycosylation, steps 1 and 2: GDP-Fuc, M g2+ (5 ml) in 100 mM Tris-HCl (pH 8.0) and 1,2FucT (5 ml) were added to the reaction vessel to form a solution (10 ml) as below: 10 mM GDPFuc, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 2.5 mg of 1,2-FucT, and 4 mM resin-bound sugar;
step 3: the temperature of the reaction mixture was maintained at 25°C under 10 W of microwave
irradiation. Glycosyl reaction was done at 25°C for 6 h (microwave 10 W, hold 6 h at 25°C, bubble
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on for 5 s, off for 600 s); step 4: The temperature of the reaction mixture was quickly brought up
to 90°C under 50 W of microwave irradiation. It was kept at 90°C for 10 min and drained to push
out all the waste to leave resin-bound sugar only (microwave 50 W, hold 10 min at 90°C, bubble
on for 1 s, off for 3 s, drain for 100 s); steps 5 and 6: GDP-Fuc, M g2+ (5 ml) in 100 mM Tris-HCl
(pH 8.0) and 1,2-FucT (5 ml) were added to the reaction vessel to form a solution (10 ml) as below:
10 mM GDP-Fuc, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 2.5 mg of 1,2-FucT, and 4 mM resinbound sugar; step 7: the temperature of the reaction mixture was maintained at 25°C under 10 W
of microwave irradiation. Glycosyl reaction was done at 25°C for 6 h (microwave 10 W, hold 6 h
at 25°C, bubble on for 5 s, off for 600 s); step 8: The temperature of the reaction mixture was
quickly brought up to 90°C under 50 W of microwave. It was kept at 90°C for 10 min and drained
to push out all the waste to leave resin-bound sugar only (microwave 50 W, hold 10 min at 90°C,
bubble on for 1 s, off for 3 s, drain for 100 s). After two cycles, the resin-bound sugar was
transferred to a flask and the sugar released under 1 M H 2 O2 (PH=10). The final compound 7 (13
mg) was purified by HPLC (water/acetonitrile, 80-54.2, 34 min/45 min) in 35% yield from
compound 12. 1 H-NM R (600 M Hz, D2O), δ 5.24 (d, J = 2 Hz, 1H), 4.64 (d, J = 5.6 Hz, 1H), 4.48
(d, J = 5.2 Hz, 1H), 4.37 (d, J = 5.2 Hz, 1H), 4.15 (m, 1H), 4.07 (m, 1H ), 3.98 (m, 2H), 3.82 (m,
2H), 3.74-3.47 (m, 22H), 3.40-3.07 (m, 4H), 1.97 (s, 3H), 1.81 (m, 2H), 1.16 (d, J = 4.4 Hz, 3H).
HRM S (ESI): m/z [M +Na]+ calcd for C35H62N2O25 933.3524; found: 933.3592.

Scheme 10
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Fully automated enzymatic synthesis of Blood A on our automated synthesizer. A synthetic
program was made for compound 8 and this program contains three cycles (table 2.1). Compound
12 was loaded into the reaction vessel and all the enzyme and sugar nucleotide solutions were
added to the corresponding tubes. The following procedures were performed by the program on
the automated synthesizer. For the first glycosylation, steps 1 and 2: UDP-Gal, M g2+ (5 ml) in 100
mM Tris-HCl (pH 8.0), and LgtB (5 ml) were added to the reaction vessel to form a solution (10
ml) as below: 10 mM UDP-Gal, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 1.0 mg of LgtB, and 4
mM compound 12; step 3: the temperature of the reaction mixture was maintained at 25°C under
10 W of microwave irradiation. Glycosyl reaction was done at 25°C for 6 h (microwave 10 W,
hold 6 h at 25°C, bubble on for 5 s, off for 600 s); step 4: The temperature of the reaction mixture
was quickly brought up to 90°C under 50 W of microwave irradiation. It was kept at 90°C for 10
min and drained to push out all the waste to leave resin-bound sugar only (microwave 50 W, hold
10 min at 90°C, bubble on for 1 s, off for 3 s, drain for 100 s); steps 5 and 6: UDP-Gal, M g2+ (5
ml) in 100 mM Tris-HCl (pH 8.0), and LgtB (5 ml) were added to the reaction vessel to form a
solution (10 ml) as below: 10 mM UDP-Gal, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 1.0 mg of
LgtB, and 4 mM resin-bound sugar; step 7: the temperature of the reaction mixture was maintained
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at 25°C under 10 W of microwave irradiation. Glycosyl reaction was done at 25°C for 6 h
(microwave 10 W, hold 6 h at 25°C, bubble on for 5 s, off for 600 s); step 8: The temperature of
the reaction mixture was quickly brought up to 90°C under 50 W of microwave irradiation. It was
kept at 90°C for 10 min and drained to push out all the waste to leave resin-bound sugar only
(microwave 50 W, hold 10 min at 90°C, bubble on for 1 s, off for 3 s, drain for 100 s). For second
glycosylation, steps 1 and 2: GDP-Fuc, M g2+ (5 ml) in 100 mM Tris-HCl (pH 8.0), and 1,2-FucT
(5 ml) were added to the reaction vessel to form a solution (10 ml) as below: 10 mM GDP-Fuc, 50
mM Tris-HCl (pH 8.0), 5 mM M g2+, 2.5 of 1,2-FucT, and 4 mM resin-bound sugar; step 3: the
temperature of the reaction mixture was maintained at 25°C under 10 W of microwave irradiation.
Glycosyl reaction was done at 25°C for 6 h (microwave 10 W, hold 6 h at 25°C, bubble on for 5
s, off for 600 s); step 4: The temperature of the reaction mixture was quickly brought up to 90°C
under 50 W of microwave irradiation. It was kept at 90°C for 10 min and drained to push out all
the waste to leave resin-bound sugar only (microwave 50 W, hold 10 min at 90°C, bubble on for
1 s, off for 3 s, drain for 100 s); steps 5 and 6: GDP-Fuc, M g2+ (5 ml) in 100 mM Tris-HCl (pH
8.0), and 1,2-FucT (5 ml) were added to the reaction vessel to form a solution (10 ml) as below:
10 mM GDP-Fuc, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 2.5 of 1,2-FucT, and 4 mM resin-bound
sugar; step 7: the temperature of the reaction mixture was maintained at 25°C under 10 W of
microwave irradiation. Glycosyl reaction was done at 25°C for 6 h (microwave 10 W, hold 6 h at
25°C, bubble on for 5 s, off for 600 s); step 8: The temperature of the reaction mixture was quickly
brought up to 90°C under 50 W of microwave. It was kept at 90°C for 10 min and drained to push
out all the waste to leave resin-bound sugar only (microwave 50 W, hold 10 min at 90°C, bubble
on for 1 s, off for 3 s, drain for 100 s). For the third glycosylation, steps 1 and 2: UDP-GalNAc,
M g2+ (5 ml) in 100 mM Tris-HCl (pH 8.0), and BgtA (5 ml) were added to the reaction vessel to
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form a solution (10 ml) as below: 10 mM UDP-GalNAc, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+,
1.9 mg of GTA, and 4 mM resin-bound sugar; step 3: the temperature of the reaction mixture was
maintained at 25°C under 10 W of microwave irradiation. Glycosyl reaction was done at 25°C for
6 h (microwave 10 W, hold 6 h at 25°C, bubble on for 5 s, off for 600 s); step 4: The temperature
of the reaction mixture was quickly brought up to 90°C under 50 W of microwave irradiation. It
was kept at 90°C for 10 min and drained to push out all the waste to leave resin-bound sugar only
(microwave 50 W, hold 10 min at 90°C, bubble on for 1 s, off for 3 s, drain for 100 s); steps 5 and
6: UDP-GalNAc, M g2+ (5 ml) in 100 mM Tris-HCl (pH 8.0), and BgtA (5 ml) were added to the
reaction vessel to form a solution (10 ml) as below: 10 mM UDP-GalNAc, 50 mM Tris-HCl (pH
8.0), 5 mM M g2+, 1.9 mg of GTA, and 4 mM resin-bound sugar; step 7: the temperature of the
reaction mixture was maintained at 25°C under 10 W of microwave irradiation. Glycosyl reaction
was done at 25°C for 6 h (microwave 10 W, hold 6 h at 25°C, bubble on for 5 s, off for 600 s);
step 8: The temperature of the reaction mixture was quickly brought up to 90°C under 50 W of
microwave irradiation. It was kept at 90°C for 10 min and drained to push out all the waste to leave
resin-bound sugar only (microwave 50 W, hold 10 min at 90°C, bubble on for 1 s, off for 3 s, drain
for 100 s). After three cycles, the resin-bound sugar was transferred to a flask and the sugar
released under 1 M H 2 O2 (PH=10). The final compound 8 (14 mg) was purified by HPLC
(water/acetonitrile,75-35, 31min/35min) in 29% yield from compound 12. 1 H-NM R (600 MHz,
D2O), δ 5.29 (d, J = 2.4 Hz, 1H), 5.11 (d, J = 1.6 Hz, 1H), 4.64 (d, J = 5.2 Hz, 1H), 4.54 (d, J =
5.6 Hz, 1H), 4.45 (d, J = 5.6 Hz, 1H), 4.38 (d, J = 4.8 Hz, 1H), 4.25 (m, 1H), 4.18 (m, 3H), 4.07
(m, 1H ), 3.97-3.83 (m, 9H), 3.76-3.55 (m, 20H), 3.38-3.08 (m, 4H), 1.99 (m, 8H), 1.18 (d, J = 4.4
Hz, 3H). HRM S (ESI): m/z [M +H]+ calcd for C43H75N3O30 1114.4508; found: 1114.4485.
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Scheme 11

Fully automated enzymatic synthesis of Blood B on our automated synthesizer. A synthetic
program was made for compound 9 and this program contains three cycles (table 2.1). Compound
12 was loaded into the reaction vessel and all the enzyme and sugar nucleotide solutions were
added to the corresponding tubes. The following p rocedures were performed by the program on
the automated synthesizer. For the first glycosylation, steps 1 and 2: UDP-Gal, M g2+ (5 ml) in 100
mM Tris-HCl (pH 8.0), and LgtB (5 ml) were added to the reaction vessel to form a solution (10
ml) as below: 10 mM UDP-Gal, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 1.0 mg of LgtB, and 4
mM compound 12; step 3: the temperature of the reaction mixture was maintained at 25°C under
10 W of microwave irradiation. Glycosyl reaction was done at 25°C for 6 h (microwave 10 W,
hold 6 h at 25°C, bubble on for 5 s, off for 600 s); step 4: The temperature of the reaction mixture
was quickly brought up to 90°C under 50 W of microwave. It was kept at 90°C for 10 min and
drained to push out all the waste to leave resin-bound sugar only (microwave 50 W, hold 10 min
at 90°C, bubble on for 1 s, off for 3 s, drain for 100 s); steps 5 and 6: UDP-Gal, M g2+ (5 ml) in
100 mM Tris-HCl (pH 8.0), and LgtB (5 ml) were added to the reaction vessel to form a solution
(10 ml) as below: 10 mM UDP-Gal, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 1.0 mg of LgtB, and
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4 mM resin-bound sugar; step 7: the temperature of the reaction mixture was maintained at 25°C
under 10 W of microwave. Glycosyl reaction was done at 25°C for 6 h (microwave 10 W, hold 6
h at 25°C, bubble on for 5 s, off for 600 s); step 8: The temperature of the reaction mixture was
quickly brought up to 90°C under 50 W of microwave. It was kept at 90°C for 10 min and drained
to push out all the waste to leave resin-bound sugar only (microwave 50 W, hold 10 min at 90°C,
bubble on for 1 s, off for 3 s, drain for 100 s). For the second glycosylation, steps 1 and 2: GDPFuc, M g2+ (5 ml) in 100 mM Tris-HCl (pH 8.0), and 1,2-FucT (5 ml) were added to the reaction
vessel to form a solution (10 ml) as below: 10 mM GDP-Fuc, 50 mM Tris-HCl (pH 8.0), 5 mM
M g2+, 2.5 mg of 1,2-FucT, and 4 mM resin-bound sugar; step 3: the temperature of the reaction
mixture was maintained at 25°C under 10 W of microwave irradiation. Glycosyl reaction was done
at 25°C for 6 h (microwave 10 W, hold 6 h at 25°C, bubble on for 5 s, off for 600 s); step 4: The
temperature of the reaction mixture was quickly brought up to 90°C under 50 W of microwave. It
was kept at 90°C for 10 min and drained to push out all the waste to leave resin-bound sugar only
(microwave 50 W, hold 10 min at 90°C, bubble on for 1 s, off for 3 s, drain for 100 s); steps 5 and
6: GDP-Fuc, M g2+ (5 ml) in 100 mM Tris-HCl (pH 8.0), and 1,2-FucT (5 ml) were added to the
reaction vessel to form a solution (10 ml) as below: 10 mM GDP-Fuc, 50 mM Tris-HCl (pH 8.0),
5 mM M g2+, 2.5 mg of 1,2-FucT, and 4 mM resin-bound sugar; step 7: the temperature of the
reaction mixture was maintained at 25°C under 10 W of microwave irradiation. Glycosyl reaction
was done at 25°C for 6 h (microwave 10 W, hold 6 h at 25°C, bubble on for 5 s, off for 600 s);
step 8: The temperature of the reaction mixture was quickly brought up to 90°C under 50 W of
microwave irradiation. It was kept at 90°C for 10 min and drained to push out all the waste to leave
resin-bound sugar only (microwave 50 W, hold 10 min at 90°C, bubble on for 1 s, off for 3 s, drain
for 100 s). For the third glycosylation, steps 1 and 2: UDP-Gal, M g2+ (5 ml) in 100 mM Tris-HCl
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(pH 8.0), and GTB (5 ml) were added to the reaction vessel to form a solution (10 ml) as below:
10 mM UDP-Gal, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 1.8 mg of GTB, and 4 mM resin-bound
sugar; step 3: the temperature of the reaction mixture was maintained at 25°C under 10 W of
microwave irradiation. Glycosyl reaction was done at 25°C for 6 h (microwave 10 W, hold 6 h at
25°C, bubble on for 5 s, off for 600 s); step 4: The temperature of the reaction mixture was quickly
brought up to 90°C under 50 W of microwave. It was kept at 90°C for 10 min and drained to push
out all the waste to leave resin-bound sugar only (microwave 50 W, hold 10 min at 90°C, bubble
on for 1 s, off for 3 s, drain for 100 s); steps 5 and 6: UDP-Gal, M g2+ (5 ml) in 100 mM Tris-HCl
(pH 8.0), and GTB (5 ml) were added to the reaction vessel to form a s olution (10 ml) as below:
10 mM UDP-Gal, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 1.8 mg of GTB, and 4 mM resin-bound
sugar; step 7: the temperature of the reaction mixture was maintained at 25°C under 10 W of
microwave irradiation. Glycosyl reaction was done at 25°C for 6 h (microwave 10 W, hold 6 h at
25°C, bubble on for 5 s, off for 600 s); step 8: The temperature of the reaction mixture was quickly
brought up to 90°C under 50 W of microwave. It was kept at 90°C for 10 min and drained to push
out all the waste to leave resin-bound sugar only (microwave 50 W, hold 10 min at 90°C, bubble
on for 1 s, off for 3 s, drain for 100 s). After three cycles, the resin-bound sugar was transferred to
a flask and the sugar released under 1 M H 2 O 2 (PH=10). The final compound 9 (13 mg) was
purified by HPLC (water/acetonitrile,75-35, 28min/35min) in 27.1% yield from compound 12. 1 HNM R (600 M Hz, D2O), δ 5.21 (m, 1H), 5.13 (m, 1H), 4.59 (d, J = 5.2 Hz, 1H), 4.52 (d, J = 4.8
Hz, 1H), 4.40 (d, J = 5.2 Hz, 1H), 4.33 (d, J = 5.2 Hz, 1H), 4.19 (m, 2H), 4.08 (m, 1H), 4.03 (m,
1H ), 3.86-3.53 (m, 31H), 3.33-3.04 (m, 4H), 2.00-1.90 (m, 5H), 1.20 (m, 3H). HRM S (ESI): m/z
[M +H]+ calcd for C41H72N2O30 1073.4243; found: 1073.4229.
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Scheme 12

Fully automated enzymatic synthesis of PolyLacNAc on our automated synthesizer. A synthetic
program was made for compound 10 and this program contains nine cycles (table 2.1). Compound
12 was loaded into the reaction vessel and all the enzyme and sugar nucleotide solutions were
added to the corresponding tubes. For the first glycosylation, steps 1 and 2: UDP-Gal, M g2+ (5 ml)
in 100 mM Tris-HCl (pH 8.0), and LgtB (5 ml) were added to the reaction vessel to form a solution
(10 ml) as below: 10 mM UDP-Gal, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 1.0 mg of LgtB, and
4 mM compound 12; step 3: the temperature of the reaction mixture was maintained at 25°C under
10 W of microwave irradiation. Glycosyl reaction was done at 25°C for 6 h (microwave 10 W,
hold 6 h at 25°C, bubble on for 5 s, off for 600 s); step 4: The temperature of the reaction mixture
was quickly brought up to 90°C under 50 W of microwave irradiation. It was kept at 90°C for 10
min and drained to push out all the waste to leave resin-bound sugar only (microwave 50 W, hold
10 min at 90°C, bubble on for 1 s, off for 3 s, drain for 100 s); steps 5 and 6: UDP-Gal, M g2+ (5
ml) in 100 mM Tris-HCl (pH 8.0), and LgtB (5 ml) were added to the reaction vessel to form a
solution (10 ml) as below: 10 mM UDP-Gal, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 1.0 mg of
LgtB, and 4 mM resin-bound sugar; step 7: the temperature of the reaction mixture was maintained
at 25°C under 10 W of microwave irradiation. Glycosyl reaction was done at 25°C for 6 h
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(microwave 10 W, hold 6 h at 25°C, bubble on for 5 s, off for 600 s); step 8: The temperature of
the reaction mixture was quickly brought up to 90°C under 50 W of microwave irradiation. It was
kept at 90°C for 10 min and drained to push out all the waste to leave resin-bound sugar only
(microwave 50 W, hold 10 min at 90°C, bubble on for 1 s, off for 3 s, drain for 100 s). For the
second glycosylation, steps 1 and 2: UDP-GlcNAc, M g2+ (5 ml) in 100 mM Tris-HCl (pH 8.0),
and LgtA (5 ml) were added to the reaction vessel to form a solution (10 ml) as below: 10 mM
UDP-GlcNAc, 50 mM Tris-HCl (pH 8.0), 4 mM M g2+, 1.7 mg of LgtA, and 4 mM resin-bound
sugar; step 3: the temperature of the reaction mixture was maintained at 25°C under 10 W of
microwave irradiation. Glycosyl reaction was done at 25°C for 12 h (microwave 10 W, hold 12 h
at 25°C, bubble on for 5 s, off for 600 s. This is a special case and all the other glycosyl reactions
were kept for 6 h); step 4: The temperature of the reaction mixture was quickly brought up to 90°C
under 50 W of microwave irradiation. It was kept at 90°C for 10 min and drained to push out all
the waste to leave resin-bound sugar only (microwave 50 W, hold 10 min at 90°C, bubble on for
1 s, off for 3 s, drain for 100 s); steps 5 and 6: UDP-GlcNAc, M g2+ (5 ml) in 100 mM Tris-HCl
(pH 8.0), and LgtA (5 ml) were added to the reaction vessel to form a solution (10 ml) as below:
10 mM UDP-GlcNAc, 50 mM Tris-HCl (pH 8.0), 4 mM M g2+, 1.7 mg of LgtA, and 4 mM resinbound sugar; step 7: the temperature of the reaction mixture was maintained at 25°C under 10 W
of microwave irradiation. Glycosyl reaction was done at 25°C for 12 h (microwave 10 W, hold 12
h at 25°C, bubble on for 5 s, off for 600 s. This is a special one and all the other glycosyl reactions
were kept for 6 h); step 8: The temperature of the reaction mixture was quickly brought up to 90°C
under 50 W of microwave irradiation. It was kept at 90°C for 10 min and drained to push out all
the waste to leave resin-bound sugar only (microwave 50 W, hold 10 min at 90°C, bubble on for
1 s, off for 3 s, drain for 100 s). To obtain a longer polyLacNAc, these two cycles were repeated.
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After nine cycles, the resin-bound sugar was transferred to a flask and the sugar released under 1
M H 2 O2 (PH=10). The final compound 10 (8 mg) was purified by HPLC (water/acetonitrile,6045, 14min/40min) in 9.0% yield from compound 12. 1 H-NM R (600 M Hz, D2O), δ 4.68 (m, 4H),
4.44 (m, 8H), 4.09 (m, 6H), 4.00 (m, 1H), 3.92 (m, 6H), 3.79-3.64 (m, 39H), 3.61-3.46 (m, 14H),
3.28 (m, 1H), 3.10 (m, 3H), 2.01-1.93 (m, 14H). HRM S (ESI): m/z [M +H+Na]2+ calcd for
C85H144N6O61 1124.4158; found: 1124.4159.
2.7

Conclusion

In summary, a fully machine-driven system based on enzymatic glycosylation has been developed
for the automated synthesis of oligosaccharides. Several important oligosaccharides (GM 1, Blood
O, A, and B antigens, and Poly-LacNAc) were selected and successfully prepared in an automated
manner. The use of a temperature-dependent polymer, which is soluble in water at room
temperature and insoluble at elevated temperatures, overcomes limitations of solid-phase
enzymatic synthesis. It allows for both aqueous-phase reactions and solid product separation.
This study represents a proof-of-concept demonstration that enzymatic synthesis of
oligosaccharides can be achieved in an automated manner using a commercially available peptide
synthesizer. This work will enable the development of an improved instrument for automated
oligosaccharide synthesis in the future. Such improvements should include more storage tubes for
enzymes and glycosylation donors, a temperature control system for enzyme storage, a detection
system for monitoring reaction processes, more reaction vessels to perform multi-oligosaccharide
syntheses simultaneously, and a larger reaction vessel to perform large-scale reactions. M oreover,
a database on enzymatic reaction kinetics of glycosyltransferase enzymes should also be developed
and built into the control program in future studies, which will help to improve the automation
process by optimizing reaction time and enzyme usage.
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3

S ECOND GENERATION AUTOMATED PLATFORM

Glycoproteins are proteins containing oligosaccharide chains linked through covalent
bonds. M ost of them are important internal membrane proteins (IM Ps), where they play a variety
of important biological and physiological roles in living organisms.2,

3, 5, 59-61

IM Ps include

transporters, linkers, channels, receptors, enzymes, cell attachment recognition site (cell-cell
interactions) and so on. Ease of access to targets is vital for research into the relationship between
structure and function of glycoproteins. Glycopeptides, fragments of glycoproteins, have been
used to study the physiological and biological activity of their original glycoproteins. At the same
time, glycopeptides have many important biological and medical applications. T hey have been
used in clinical diagnostics, disease therapy, and biotechnological tools. 62,

63

However,

glycopeptides contain both a peptide chain and one or more oligosaccharide chains, the
combination of which makes synthesis more complex.6 Two major approaches have been reported
for glycopeptide synthesis. Briefly, the peptide chain could first be synthesized by solid phase
peptide synthesis in an organic phase system after which the oligosaccharide portion would be
built up through enzymatic reactions in an aqueous phase system. 64 The other strategy is to first
prepare an amino acid building block already containing the oligosaccharide and then incorporate
the amino acid into a peptide by conventional solid phase peptide synthesis much like any other
amino acid.6 Both ways need skilled researchers to perform synthetic process, which is a timeconsuming and labor-intensive process.
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Figure 3.1 Difference of Traditional Peptide Resins and Silica Gel
Automated synthesis allows non-specialists to rapidly prepare compounds which could save
considerable time and labor. A number of synthesizers have been developed for automated
assembly of the natural biopolymers (oligosaccharides, oligonucleotides and oligopeptides) since
solid phase peptide synthesis was first reported by R. B. M errifield in 1963.7, 8, 27 Over the past
few decades, many advanced automated synthesizers have been put into market to produce almost
every possible oligopeptide and oligonucleotide which has greatly advanced the fields of biology
and medicine. In 2001, a chemical automated platform was created for oligosaccharide synthesis
by Seeberger and co-workers using a solid phase methodology based on a commercially available
peptide synthesizer.13 Subsequently, Seeberger developed his own glycan synthesizer (Glyconeer
2.1) which uses polystyrene as solid support. 43 These approaches are based on M errifield’s concept,
where a growing compound is first attached on a solid support through a cleavable linker, allowing
purification by simple washing steps and release of the compound after several automated cycles.
All the resins which are used as solid supports are highly porous (Figure 3.1) allowing internal
attachment of primers to increase loading efficiency. In 2018, G. J. Boons and our group found
that these holes block enzymatic glycosylation and published two independent papers on
enzymatic automated synthesis based on water soluble resins. 65, 66 Nevertheless, all these reported
automated platforms can only be used to synthesize peptides, nucleotides, and saccharides, but not
glycopeptides. Herein, we report an automated platform for the preparation of glycopeptides
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(Figure 3.2). This platform is based on the use of a silica gel solid support, a peptide synthesizer
to prepare a peptide chain in an organic phase system, and another peptide synthesizer to perform
enzymatic glycosylation in an aqueous phase system.

Figure 3.2 Automated Process of Glycopeptides

3.1

Resin

The key point for automated process of glycopeptide synthesis is that the reaction and separation
steps are performed in both organic (peptide chain) and water phase (oligosaccharide chain). The
traditional solid resins can be used for two solvent system synthesis and have highly loading
efficiency, but they are only suitable for small molecule synthesis, as the tiny holes inside would
block enzymatic reactions. The water-soluble resins, which are used for enzymatic glycosylation,23,
67

are hardly used for automated processes in organic phase systems. It is necessary to find an ideal

resin which could be used to achieve our goal. In our design, an aminopropyl silica resin is used
as a solid support because it is compatible with both water and organic solvents, although it has a
much lower loading efficiency that traditional solid resin. In 1994, Chi-Huey Wong’s group

46

reported that this resin can be used for solid phase enzymatic synthesis with a 0.2 mmol/g loading
efficiency.68 A trisaccharide was successfully synthesized by using the solid resin in ideal scale.

Figure 3.3 Conjugation of Oligosaccharide Primer (Trisaccharide) with Silica Resin
through a Cleavable Linker
{𝑊[𝑅𝑒𝑠𝑖𝑛 ] − 𝑊[𝑂𝑟𝑖𝑔𝑖𝑛𝑎𝑙 𝑅𝑒𝑠𝑖𝑛 ] }
⁄𝑀𝑤
[𝑃𝑟𝑖𝑚𝑒𝑟+𝐿𝑖𝑛𝑘𝑒𝑟]
Loading Efficiency =
𝑊[𝑅𝑒𝑠𝑖𝑛 ]
Release Efficiency =

3.2

𝑊[𝑅𝑒𝑠𝑖𝑛 ] − 𝑊[𝑅𝑒𝑙𝑒𝑎𝑠𝑒𝑑 𝑅𝑒𝑠𝑖𝑛]
× 100%
𝑊[𝑅𝑒𝑠𝑖𝑛] ∗ 𝐿𝑜𝑎𝑑𝑖𝑛𝑔 𝐸𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑐𝑦

Linker

In our design, an aminopropyl silica resin is used as a solid support because it is compatible with
both water and organic solvents, although it has a much lower loading efficiency that traditional
solid resin. In 1994, Chi-Huey Wong’s group reported that this resin can be used for solid phase
enzymatic synthesis with a 0.2 mmol/g loading efficiency.68 With a large density of amino group
on the surface (Figure 3.1), a cleavable linker is easily attached to the silica resin. Usually, cleavage
of a removable linker requires exposure to either harsh acidic or basic condtions. However, glycans
are not stable in strong acids and peptides can undergo racemization in strongly basic conditions.
M oreover, the side chain of cysteine can be damaged under oxidation condition. In 1991,
Glu¨senkamp’s group reported 3,4-diethoxy-3-cyclobuten-1,2-dione (squaric acid diethyl ester) as
a cleavable linker.69 This linker can release a compound with a terminal NH2 in a 5% hydrazine
aqueous solution (Figure 3.3). Compound 1 was linked to the solid support through the squaric
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acid linker, giving a loading efficiency of 0.1 to 0.2 mmol/g of dry silica resin (Figure 2C). Excess
amino groups were then capped using acetic anhydride. To test the cleavage efficiency of this
linker, compound 4 was treated with 5% hydrazine aqueous solution. The release efficiency is
calculated by the given equation. M ore than 90% of the compound was released in less than 12 h.
3.3

Reaction efficiency

Figure 3.4 Enzymatic Activity Test in the Solid Phase Synthesis
In addition, we also tested the enzymatic activity of many glycotransferases on the silica resin. β1,4-galactosyltransferase (Lgt B) was chosen as an example to test the enzymatic activity in the
solid phase synthesis (Figure 3.4). Compound 4, prepared as described above, was used as the
glycosylation primer. To the reaction vessel, 500 mg (50 umol) of conjugated silica resin
(compound 4) was loaded. The automated synthetic process was then started by automatically
injecting Lgt B (10 mg), UDP-Gal (3 equiv), and reaction buffer (10 mL, pH 8.0). Once the
reaction finished (24 h), unreacted materials and by -products were removed by filtration under
high pressure. The silica resin was washed and taken out. Compound 5 and 5% aqueous hydrazine
(5 ml) were put into a column. After the reaction finished (12 h), the filtration was collected and a
HPLC performed. The results show that more than 80% trisaccharide was converted to
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tetrasaccharide (Figure 3.4). In a similar manner, the enzymatic activities of 1,2-Fuc T, Gt A and
Gt B were obtained (Figure 3.5).70-72 After 24 h reactions, the activities ranged from 62% to 80%.
It turns out that most of the sugars can be put on another monosaccharide after two repetitions of
the same enzymatic glycosylation step (double coupling).

Figure 3.5 Enzyme Activity (GtA, GtB and 1,2-Fuc T)
3.4

Instrument

Finally, a CEM Liberty Blue peptide synthesizer was employed to perform the designed
automation process according to previous reports. The synthesizer can perfectly prepare the
peptide part without any modification. As it was reported previously, the synthesizer can be used
for oligosaccharide chain synthesis with some modifications. The program for automated
enzymatic reactions is easily added to the Liberty Blue software (Details are shown in Table 3.1).
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Function

Table 3.1 Automated Programm for Enzymatic Glycosylations
Step
Command

Add reagent

1

Add sugar nucleotide buffer

Add reagent

2

Add enzyme buffer

M icrowave method

3

Hold 24 h at 37℃, bubble on for 5 s, off for 600 s, drain 100s

Add reagent

4

Add sugar nucleotide buffer

Add reagent

5

Add enzyme buffer

M icrowave method

6

Hold 24 h at 37℃, bubble on for 5 s, off for 600 s, drain 100s

Wash

7

3.5

Automated Process

Compound 10 was chosen as a target to test our platform (Figure 3.7). The first amino acid was
attached to the resin by manual operation (Figure 3.6). M ucin 1 is a glycoprotein with extensive
O-linked glycosylation, which is overexpressed on the surface of many cancers. The study of
M ucin 1 may prove useful in the clinical diagnosis and treatment of cancer. The PAHGVSSAPD
peptide is a repeat unit of M ucin 1, which involves nine reactions from the first amino acid (Asp)
(Figure 3.7). The automated synthesis of the peptide backbone was controlled by the original
program protocols. Compound 8 (1 g) was used a starting material and put into the reaction vessel
of peptide synthesizer. The synthesizer was programmed to add deprotection solution (20%
piperidine of DM F solution, 6 ml). After 3 min, the solution was removed by filtration. Additional
deprotection solution was added and filtration performed again after 3min. The resin was washed
three times with DM F (10 ml * 3). Then Fmoc-Pro-OH (5 ml), HATU (2 ml) and DIEA (2 ml)
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were injected into the reaction vessel to couple the second amino acid. The solution was removed
by filtration after 10 min. The coupling reaction was performed one more time and the resin was
washed three times with DM F (10 ml * 3) for the next reaction cycle. The program was set up to
perform nine cycles (all the details are provided in methods). The resin was taken out and ready to
be used for enzymatic glycosylation. Half of the samples were shaken with 5% hydrazine to release
the peptide and the solution collected by filtration. After HPLC purification, 10 mg of peptide was
obtained in 12.9% yield from compound 8. The product was confirmed by NM R and M S analysis
(see Appendix B).

Figure 3.6 Loading the First Amino Acid
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Figure 3.7 Automated Synthesis Process of Glycopeptide
Compound 12 was prepared by extending the oligosaccharide chain with enzymatic glycosylations.
Blood A epitope contains three glycosylation reactions from core 2. The enzymes used were Lgt
B, 1,2-Fuc T and Gt A (Figure 3.7). All the steps were automated and performed under the control
of a new program, which was designed for enzymatic reactions. The resin (compound 9) was
transferred to a new reaction vessel. LgtB (5 mg), UDP-Gal (2 equiv), and reaction buffer (10 mL,
pH 8.0) were automated injected to the vessel under the control of the program. Once this reaction
finished (12 h), unreacted materials and by-products were removed by filtration. The enzymatic
glycosylation reaction was performed one more time and the resin was washed three times with
water (10 ml * 3). The program was set up to perform three enzymatic reactions catalyzed by Lgt
B, 1,2-Fuc T and Gt A to generate Compound 11. Compound 11 was treated with 5% hydrazine
to release the peptide and the solution collected by filtration. After HPLC purification, 10 mg of
peptide was obtained in 11.8% yield from compound 8. The product was confirmed by NM R and
M S analysis (see Appendix B).
3.6

Results

In a similar automated manner, compounds 13-20 were prepared using enzymes reported
previously. All the targets were purified by HPLC to give highly pure compounds. All p roducts
were confirmed by NM R and M S analysis (see Appendix B).
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Figure 3.8 Targets That Were Used to the Test Automated System in This Work
3.7

Materials and General Methods
All commercially available solvents and reagents were used without purification. Silica

Gel Resin was purchased from Fisher Scientific (USA). 3,4-diethoxy-3-cyclobuten-1,2-dione was
purchased from M illiporeSigma. N-Acetylneuraminic acid (Neu5Ac) and cytidine 5'-triphosphate
(CTP) were purchased from Carbosynth Limited. Sugar nucleotides uridine 5’-diphosphogalactose (UDP-Gal), UDP-N-acetylglucosamine (UDP-GlcNAc), UDP-N-acetylgalactosamine
(UDP-GalNAc), and guanosine 5’-diphospho-L-fucose (GDP-Fuc) were prepared as described
previously. Helicobacter pylori β1,3-N-acetylglucosaminyltransferase (HpLgtA), Neisseria
meningitides

β1,4-galactosyltransferase

(NmLgtB),

Helicobacter

mustelae

α1,2

-

fucosyltransferase, Helicobacter mustelae α1,3-N-acetyl-galactosaminyltransferase (BgtA), and
human blood group B glycosyltransferase (GTB) were expressed and purified as described
previously.
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H-NM R and 13 C-NM R spectra were recorded by using a Bruker 400 spectrometer

(400 M Hz for 1 H, 100 M Hz for 13 C) or a Bruker 600 spectrometer (600 M Hz for 1 H, 150 M Hz for
13

C). All 1H Chemical shifts (in ppm) were assigned in reference to CDCl3 (δ= 7.24 ppm), MeOD

(δ= 4.87 ppm), and D 2 O (δ = 4.79 ppm) and all

13

C NM R was calibrated with CDCl3 (δ = 77.00

ppm). HPLC was performed on Shimadzu Prominence UFLC. Column: Waters XBridge BEH
amide column, 130 Å, 5 μm, 4.6 mm × 250 mm. Semi-praparative Waters XBridge BEH amide
column (130 Å, 5 μm, 10 mm × 250 mm) was applied for purification. Solvent A: 100 mM
ammonium formate, pH 3.2. Solvent B: Acetonitrile. Semi-praparative Agilent Eclipse XDB-C18,
5 μm, 9.4 × 250 mm. Aeris PEPTIDE 3.6 µm CB-C18, 4.6 mm x 250 mm. Solvent A: 0.1% TFA
Water. Solvent B: 0.1% Acetonitrile. High-resolution electrospray ionization mass spectrometry
(ESI-HRM S) experiment was performed on an LTQ-Orbitrap Elite mass spectrometer (Thermo
Fisher).
Automated synthesis was performed on a Liberty Blue peptide synthesizer according to
the basic manufacture’s manual and software for controlling operation with a designated program
(Table 3.1) and sequence for the synthesis of the present target compounds.

S ynthesis.
S cheme 1
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Compound 4 was prepared from amino group functional silica resin. In detail, compound 2 (1 g)
was dispersed in the DM F (10 ml). 3,4-diethoxy-3-cyclobuten-1,2-dione (850 mg, 5 mmol) and
triethylamine (1 g, 10 mmol) were added to the solution. The reaction mixture was shaken for 8 h
at room temperature and filtered to get the resin. The resin was re-dispersed in the DM F (10 ml).
3,4-diethoxy-3-cyclobuten-1,2-dione (850 mg, 5 mmol) and triethylamine (1 g, 10 mmol) were
added to the solution. The reaction mixture was shaken for 8 h at room temperature and filtered to
get the resin. The resin was re-dispersed in the DM F (10 ml). Compound 1 (625 mg, 1 mmol) and
triethylamine (1 g, 10 mmol) were added to the solution. The reaction mixture was shaken for 8 h
at room temperature and filtered to get the resin. The resin was re-dispersed in the DM F (10 ml).
Compound 1 (625 mg, 1 mmol) and triethylamine (1 g, 10 mmol) were added to the solution. The
reaction mixture was shaken for 8 h at room temperature and filtered to get the resin. The loading
efficiency was calculated by an equation.

S cheme 2
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Compound 22 was prepared from amino group functional silica resin. In detail, compound 2 (1 g)
was dispersed in the DM F (10 ml). 3,4-diethoxy-3-cyclobuten-1,2-dione (850 mg, 5 mmol) and
triethylamine (1 g, 10 mmol) were added to the solution. The reaction mixture was shaken for 8 h
at room temperature and filtered to get the resin. The resin was re-dispersed in the DM F (10 ml).
3,4-diethoxy-3-cyclobuten-1,2-dione (850 mg, 5 mmol) and triethylamine (1 g, 10 mmol) were
added to the solution. The reaction mixture was shaken for 8 h at room temperature and filtered to
get the resin. The resin was re-dispersed in the DM F (10 ml). Compound 21 (400 mg, 1 mmol)
and triethylamine (1 g, 10 mmol) were added to the solution. The reaction mixture was shaken for
8 h at room temperature and filtered to get the resin. The resin was re-dispersed in the DM F (10
ml). Compound 21 (400 mg, 1 mmol) and triethylamine (1 g, 10 mmol) were added to the solution.
The reaction mixture was shaken for 8 h at room temperature and filtered to get the resin. The
loading efficiency was calculated by an equation.

S cheme 3
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Compound 22 was prepared from amino group functional silica resin. In detail, compound 2 (1 g)
was dispersed in the DM F (10 ml). 3,4-diethoxy-3-cyclobuten-1,2-dione (850 mg, 5 mmol) and
triethylamine (1 g, 10 mmol) were added to the solution. The reaction mixture was shaken for 8 h
at room temperature and filtered to get the resin. The resin was re-dispersed in the DM F (10 ml).
3,4-diethoxy-3-cyclobuten-1,2-dione (850 mg, 5 mmol) and triethylamine (1 g, 10 mmol) were
added to the solution. The reaction mixture was shaken for 8 h at room temperature and filtered to
get the resin. The resin was re-dispersed in the DM F (10 ml). Compound 21 (545 mg, 1 mmol)
and triethylamine (1 g, 10 mmol) were added to the solution. The reaction mixture was shaken for
8 h at room temperature and filtered to get the resin. The resin was re-dispersed in the DM F (10
ml). Compound 21 (545 mg, 1 mmol) and triethylamine (1 g, 10 mmol) were added to the solution.
The reaction mixture was shaken for 8 h at room temperature and filtered to get the resin. The
loading efficiency was calculated by an equation.

Compound release experiment
S cheme 4
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Compound 4 was used to perform compound release experiment. In detail, compound 4 (200 mg)
was dispersed in the 5% hydrazine aqueous solution (5 ml). The reaction mixture was shaken for
12 h at room temperature and compound-released resin was collected by filtration. The release
efficiency was calculated by an equation.

Enzymes activity test
S cheme 5

Compound 4 was used to test the activity of Lgt B. In detail, to the reaction vessel, Compound 4
(500 mg, 50 umol) was loaded. The automated synthetic process was then started by automatically
injecting Lgt B (5 mg), UDP-Gal (3 eq), and reaction buffer (10 mL, pH 8.0). Once the reaction
finished (24 h), unreacted materials and by-products were removed by filtration under high
pressure. The silica resin was washed and taken out. Compound 5 and 5% hydrazine aqueous (5
ml) were put into a column. After the reaction finished (12 h), the filtration was collected and
injected into HPLC (water/acetonitrile, 80-54.2, 30 min/45 min). The results show that more than
80% trisaccharide was converted to tetrasaccharide (Figure 3.4).

S cheme 6
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Compound 22 was used to test the activity of 1,2 Fuc T. In detail, to the reaction vessel, Compound
22 (500 mg, 50umol) was loaded. The automated synthetic process was then started by
automatically injecting 1,2 Fuc T (6.5 mg), GDP-Fuc (3 eq), and reaction buffer (10 mL, pH 8.0).
Once the reaction finished (24 h), unreacted materials and by -products were removed by filtration
under high pressure. The silica resin was washed and taken out. Compound 24 and 5% hydrazine
aqueous (5 ml) were put into a column. After the reaction finished (12 h), the filtration was
collected and injected into HPLC (water/acetonitrile, 80-54.2, 30 min/45 min). The results show
that more than 80% trisaccharide was converted to tetrasaccharide (Figure 3.5).

S cheme 7

Compound 24 was used to test the activity of Gt A. In detail, to the reaction vessel, Compound 24
(500 mg) was loaded. The automated synthetic process was then started by automatically injecting
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GtA (5 mg), UDP-GalNAc (3 eq), and reaction buffer (10 mL, pH 8.0). Once the reaction finished
(24 h), unreacted materials and by-products were removed by filtration under high pressure. The
silica resin was washed and taken out. Compound 25 and 5% hydrazine aqueous (5 ml) were put
into a column. After the reaction finished (12 h), the filtration was collected and injected into
HPLC (water/acetonitrile, 80-54.2, 30 min/45 min). The results show that more than 60%
trisaccharide was converted to tetrasaccharide (Figure 3.5).
S cheme 8

Compound 24 was used to test the activity of Gt B. In detail, to the reaction vessel, Compound 24
(500 mg) was loaded. The automated synthetic process was then started by automatically injecting
Gt B (10 mg), UDP-Gal (3 eq), and reaction buffer (10 mL, pH 8.0). Once the reaction finished
(24 h), unreacted materials and by-products were removed by filtration under high pressure. The
silica resin was washed and taken out. Compound 27 and 5% hydrazine aqueous (5 ml) were put
into a column. After the reaction finished (12 h), the filtration was collected and injected into
HPLC (water/acetonitrile, 80-54.2, 30 min/45 min). The results show that more than 70%
trisaccharide was converted to tetrasaccharide (Figure 3.5).
S cheme 9
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Compound 8 was prepared from amino group functional silica resin. In detail, compound 2 (10 g)
was dispersed in the DM F (100 ml). 3,4-diethoxy-3-cyclobuten-1,2-dione (8.5 g, 50 mmol) and
triethylamine (10 g, 100 mmol) were added to the solution. The reaction mixture was shaken for
8 h at room temperature and filtered to get the resin. The resin was re-dispersed in the DM F (100
ml). 3,4-diethoxy-3-cyclobuten-1,2-dione (8.5 g, 50 mmol) and triethylamine (10 g, 100 mmol)
were added to the solution. The reaction mixture was shaken for 8 h at room temperature and
filtered to get the resin (Compound 3). The resin was re-dispersed in the DM F (100 ml).
Ethylenediamine (600 mg, 10 mmol) and triethylamine (10 g, 100 mmol) were added to the
solution. The reaction mixture was shaken for 8 h at room temperature and filtered to get the resin.
The resin was re-dispersed in the DM F (100 ml). Ethylenediamine (600 mg, 10 mmol) and
triethylamine (10 g, 100 mmol) were added to the solution. The reaction mixture was shaken for
8 h at room temperature and filtered to get the resin (Compound 7). The resin was re-dispersed in
the DM F (100 ml). Fmoc-Asp-OH (3.55 g,10 mmol), HATU (3.8 g, 10 mmol) and DIPEA (1.29
g, 10 mmol) were added to the solution. The reaction mixture was shaken for 1h at room
temperature and filtered to get the resin. The resin was re-dispersed in the DM F (100 ml). FmocAsp-OH (3.55 g,10 mmol), HATU (3.8 g, 10 mmol) and DIPEA (1.29 g, 10 mmol) were added to
the solution. The reaction mixture was shaken for 1h at room temperature and filtered to get the
resin (Compound 8). The loading efficiency was calculated by an equation.

Automated synthesis of oligosaccharide
S cheme 10
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Fully automated synthesis of lewis X antigen on our automated synthesizer. A synthetic program
was made for lewis X antigen and this program contains two cycles (table 3.1). Compound 4 (500
mg) was loaded into the reaction vessel and all the enzyme and sugar nucleotide solutions were
added to the corresponding tubes. The following procedures were performed by the program on
the automated synthesizer. For the first cycle, steps 1 and 2: UDP-Gal, M g2+ (5 ml) in 100 mM
Tris-HCl (pH 8.0), and LgtB (5 ml) were added to the reaction vessel to form a solution (10 ml)
as below: 10 mM UDP-Gal, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 5.0 mg of LgtB, and 5 mM
compound 9; step 3: the temperature of the reaction mixture was maintained at 37°C under 20 W
of microwave. Glycosyl reaction was done at 37°C for 12 h (microwave 20 W, hold 12 h at 37°C,
bubble on for 5 s, off for 600 s); steps 4 and 5: UDP-Gal, M g2+ (5 ml) in 100 mM Tris-HCl (pH
8.0), and LgtB (5 ml) were added to the reaction vessel to form a solution (10 ml) as below: 10
mM UDP-Gal, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 5.0 mg of LgtB, and 5 mM compound 9;
step 6: the temperature of the reaction mixture was maintained at 37°C under 20 W of microwave.
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Glycosyl reaction was done at 37°C for 12 h (microwave 20 W, hold 12 h at 37°C, bubble on for
5 s, off for 600 s); step 7: the resin was washed by water (10 ml) three times; the first cycle was
finished. For the second cycle, steps 1 and 2: GDP-Fuc, M g2+ (5 ml) in 100 mM Tris-HCl (pH 8.0),
and 1,3-FucT (5 ml) were added to the reaction vessel to form a solution (10 ml) as below: 10 mM
GDP-Fuc, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 6.5 mg of 1,3-FucT, and 5 mM compound
bound resin; step 3: the temperature of the reaction mixture was maintained at 37°C under 20 W
of microwave. Glycosyl reaction was done at 37°C for 12 h (microwave 20 W, hold 12 h at 37°C,
bubble on for 5 s, off for 600 s); steps 4 and 5: GDP-Fuc, M g2+ (5 ml) in 100 mM Tris-HCl (pH
8.0), and 1,3-FucT (5 ml) were added to the reaction vessel to form a solution (10 ml) as below:
10 mM GDP-Fuc, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 6.5 mg of 1,3-FucT, and 5 mM
compound bound resin; step 6: the temperature of the reaction mixture was maintained at 37°C
under 20 W of microwave. Glycosyl reaction was done at 37°C for 12 h (microwave 20 W, hold
12 h at 37°C, bubble on for 5 s, off for 600 s); step 7: the resin was washed by water (10 ml) three
times; the second cycle was finished. Compound X was obtained after three cycles. Compound X
was dispersed in the 5% hydrazine aqueous solution and the reaction mixture was shaken at room
temperature for 12 h. After the reaction finished (12 h), the filtration was collected and injected to
HPLC (water/acetonitrile, 5-20, 30 min/45 min) to get Lewis X antigen (5 mg) in yield 10.6%.
S cheme 11

63

Fully automated synthesis of Lewis Y antigen on our automated synthesizer. A synthetic program
was made for Lewis Y antigen and this program contains three cycles (table 3.1). Compound 4
(500 mg) was loaded into the reaction vessel and all the enzyme and sugar nucleotide solutions
were added to the corresponding tubes. The following procedures were performed by the program
on the automated synthesizer. For the first cycle, steps 1 and 2: UDP-Gal, M g2+ (5 ml) in 100 mM
Tris-HCl (pH 8.0), and LgtB (5 ml) were added to the reaction vessel to form a solution (10 ml)
as below: 10 mM UDP-Gal, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 5.0 mg of LgtB, and 5 mM
compound 9; step 3: the temperature of the reaction mixture was maintained at 37°C under 20 W
of microwave. Glycosyl reaction was done at 37°C for 12 h (microwave 20 W, hold 12 h at 37°C,
bubble on for 5 s, off for 600 s); steps 4 and 5: UDP-Gal, M g2+ (5 ml) in 100 mM Tris-HCl (pH
8.0), and LgtB (5 ml) were added to the reaction vessel to form a solution (10 ml) as below: 10
mM UDP-Gal, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 5.0 mg of LgtB, and 5 mM compound 9;
step 6: the temperature of the reaction mixture was maintained at 37°C under 20 W of microwave.
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Glycosyl reaction was done at 37°C for 12 h (microwave 20 W, hold 12 h at 37°C, bubble on for
5 s, off for 600 s); step 7: the resin was washed by water (10 ml) three times; the first cycle was
finished. For the second cycle, steps 1 and 2: GDP-Fuc, M g2+ (5 ml) in 100 mM Tris-HCl (pH 8.0),
and 1,3-FucT (5 ml) were added to the reaction vessel to form a solution (10 ml) as below: 10 mM
GDP-Fuc, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 6.5 mg of 1,3-FucT, and 5 mM compound
bound resin; step 3: the temperature of the reaction mixture was maintained at 37°C under 20 W
of microwave. Glycosyl reaction was done at 37°C for 12 h (microwave 20 W, hold 12 h at 37°C,
bubble on for 5 s, off for 600 s); steps 4 and 5: GDP-Fuc, M g2+ (5 ml) in 100 mM Tris-HCl (pH
8.0), and 1,3-FucT (5 ml) were added to the reaction vessel to form a solution (10 ml) as below:
10 mM GDP-Fuc, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 6.5 mg of 1,3-FucT, and 5 mM
compound bound resin; step 6: the temperature of the reaction mixture was maintained at 37°C
under 20 W of microwave. Glycosyl reaction was done at 37°C for 12 h (microwave 20 W, hold
12 h at 37°C, bubble on for 5 s, off for 600 s); step 7: the resin was washed by water (10 ml) three
times; the second cycle was finished. For the third cycle, steps 1 and 2: GDP-Fuc, M g2+ (5 ml) in
100 mM Tris-HCl (pH 8.0), and 1,2-FucT (5 ml) were added to the reaction vessel to form a
solution (10 ml) as below: 10 mM GDP-Fuc, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 6.5 mg of
1,2-FucT, and 5 mM compound bound resin; step 3: the temperature of the reaction mixture was
maintained at 37°C under 20 W of microwave. Glycosyl reaction was done at 37°C for 12 h
(microwave 20 W, hold 12 h at 37°C, bubble on for 5 s, off for 600 s); steps 4 and 5: GDP-Fuc,
M g2+ (5 ml) in 100 mM Tris-HCl (pH 8.0), and 1,2-FucT (5 ml) were added to the reaction vessel
to form a solution (10 ml) as below: 10 mM GDP-Fuc, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+,
5.0 mg of 1,2-FucT, and 5 mM compound bound resin; step 6: the temperature of the reaction
mixture was maintained at 37°C under 20 W of microwave. Glycosyl reaction was done at 37°C
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for 12 h (microwave 20 W, hold 12 h at 37°C, bubble on for 5 s, off for 600 s); step 7: the resin
was washed by water (10 ml) three times; the third cycle was finished. Compound X was obtained
after three cycles. Compound X was dispersed in the 5% hydrazine aqueous solution and the
reaction mixture was shaken at room temperature for 12 h. After the reaction finished (12 h), the
filtration was collected and injected to HPLC (water/acetonitrile, 5-20, 30 min/45 min) to get
Lewis Y antigen (5 mg) in 9.5yeild %.

Automated synthesis of glycopeptide
S cheme 12

Fully automated synthesis of M ucin 1 peptide (compound 10) on our automated synthesizer. A
synthetic program was made for compound 9 and this program contains ten cycles. Compound 8
(500 mg) was loaded into the reaction vessel and all the amino acid, base and activator solutions
were added to the corresponding tubes. The following procedures were performed by the program
on the automated synthesizer. For the first cycle, step 1: deprotection solution (20% piperidine in
DM F solution, 3 ml) was added to the reaction vessel; step 2: the temperature of the reaction
mixture was maintained at 50°C under 25 W of microwave. Reaction was done at 50°C for 3 min
(microwave 25 W, hold 3 min at 50°C, bubble on for 2 s, off for 3 s, drain 100 s); Step 3:
deprotection solution (20% piperidine in DM F solution, 3 ml) was added to the reaction vessel;
step 4: the temperature of the reaction mixture was maintained at 50°C under 25 W of microwave.
Reaction was done at 50°C for 3 min (microwave 25 W, hold 3 min at 50°C, bubble on for 2 s, off
for 3 s, drain 100 s); step 5: the resin was washed by DM F (10 ml) three times; step 6: Fmoc-Pro-
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OH (2.5 ml, 0.2 M ), HATU (1 ml, 0.5 M ) and DIEA (1 ml, 0.5 M ) were added to the reaction
vessel; step 7: the temperature of the reaction mixture was maintained at 50°C under 25 W of
microwave. Reaction was done at 50°C for 10 min (microwave 25 W, hold 10 min at 50°C, bubble
on for 2 s, off for 3 s, drain 100 s); step 8: Fmoc-Pro-OH (2.5 ml, 0.2 M ), HATU (1 ml, 0.5 M)
and DIEA (1 ml, 0.5 M ) were added to the reaction vessel; step 9: the temperature of the reaction
mixture was maintained at 50°C under 25 W of microwave. Reaction was done at 50°C for 10 min
(microwave 25 W, hold 10 min at 50°C, bubble on for 2 s, off for 3 s, drain 100 s); step 10: the
resin was washed by DM F (10 ml) three times; the first cycle was finished. For the second and
third cycles, the synthesizer performed the same steps as the first cycle (the corresponding amino
acid was injected following the program). For the fourth cycle (sugar amino acid cycle), step 1:
deprotection solution (20% piperidine in DM F solution, 3 ml) was added to the reaction vessel;
step 2: the temperature of the reaction mixture was maintained at 50°C under 25 W of microwave.
Reaction was done at 50°C for 3 min (microwave 25 W, hold 3 min at 50°C, bubble on for 2 s, off
for 3 s, drain 100 s); Step 3: deprotection solution (20% pip eridine in DM F solution, 3 ml) was
added to the reaction vessel; step 4: the temperature of the reaction mixture was maintained at
50°C under 25 W of microwave. Reaction was done at 50°C for 3 min (microwave 25 W, hold 3
min at 50°C, bubble on for 2 s, off for 3 s, drain 100 s); step 5: the resin was washed by DM F (10
ml) three times; step 6: Fmoc-Ser(Core 2)-OH (2.5 ml, 0.2 M ), HATU (1 ml, 0.5 M ) and DIEA (1
ml, 0.5 M ) were added to the reaction vessel; step 7: the temperature of the reaction mixture was
maintained at 50°C under 25 W of microwave. Reaction was done at 50°C for 1 h (microwave 25
W, hold 10 min at 50°C, bubble on for 2 s, off for 3 s, drain 100 s); step 8: Fmoc- Ser(Core 2)-OH
(2.5 ml, 0.2 M ), HATU (1 ml, 0.5 M ) and DIEA (1 ml, 0.5 M ) were added to the reaction vessel;
step 9: the temperature of the reaction mixture was maintained at 50°C under 25 W of microwave.
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Reaction was done at 50°C for 1 h (microwave 25 W, hold 10 min at 50°C, bubble on for 2 s, off
for 3 s, drain 100 s); step 10: the resin was washed by DM F (10 ml) three times; the fourth cycle
was finished. For the 5th to 9th cycles, the synthesizer performed the same steps as the first cycle
(the corresponding amino acid was injected following the program). For the 10th cycle, step 1:
deprotection solution (20% piperidine in DM F solution, 3 ml) was added to the reaction vessel;
step 2: the temperature of the reaction mixture was maintained at 50°C under 25 W of microwave.
Reaction was done at 50°C for 3 min (microwave 25 W, hold 3 min at 50°C, bubble on for 2 s, off
for 3 s, drain 100 s); Step 3: deprotection solution (20% piperidine in DM F solution, 3 ml) was
added to the reaction vessel; step 4: the temperature of the reaction mixture was maintained at
50°C under 25 W of microwave. Reaction was done at 50°C for 3 min (microwave 25 W, hold 3
min at 50°C, bubble on for 2 s, off for 3 s, drain 100 s); step 5: the resin was washed by DM F (10
ml) three times; step 6: cocktail (TFA:water:TIS:DODT = 92.5:2.5:2.5:2.5; 10 ml) was added to
the reaction vessel; step 7: the temperature of the reaction mixture was maintained at room
temperature without microwave. Reaction was done at room temperature for 3 h (microwave 0 W,
hold 3 h at room temperature, bubble on for 2 s, off for 3 s, drain 100 s); step 8: the resin was
washed by DM F (10 ml) three times; the 10th cycle was finished. Compound 9 was obtained after
10 cycles. Compound 9 was dispersed in the 5% hydrazine aqueous solution and the reaction
mixture was shaken at room temperature for 12 h. After the reaction finished (12 h), the filtration
was collected and injected to HPLC (water/acetonitrile, 5-20, 30 min/45 min) to get compound 10
(10 mg) in yield 12.9%. 1 H-NM R (600 M Hz, D2O), δ 8.67 (s, 1H), 7.28 (s, 1H), 4.60-4.56 (m,
2H), 4.49-4.42 (m, 3H), 4.37-4.30 (m, 4H ), 4.26-4.20 (m, 3H), 4.11 (m, 1H), 3.97-3.91 (m, 4H),
3.88-3.83 (m, 3H), 3.78-3.61 (m, 13H), 3.48-3.41 (m, 4H), 3.40-3.29 (m, 4H), 3.26-3.21 (m, 1H ),
3.16-3.12 (m, 1H), 3.09-3.07 (m, 2H), 2.88-2.78 (m, 2H), 2.41-2.36 (m, 1H), 2.26-2.20 (m, 1H),
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2.08-1.84 (m, 14H), 1.31-1.28 (m, 6H), 0.91-0.86 (m, 6H). HRM S (ESI): m/z [M +3H]3+ detected:
516.5758 m/z; calcd for C63H102N16O29 1546.6999 Da.

S cheme 13

Fully automated synthesis of compound 13 on our automated synthesizer. A synthetic program
was made for compound 29 and this program contains one enzymatic reaction cycle (table 3.1).
Compound 9 (500 mg) was loaded into the reaction vessel and all the enzyme and sugar nucleotide
solutions were added to the corresponding tubes. The following procedures were performed by the
program on the automated synthesizer. For the first cycle, steps 1 and 2: UDP-Gal, M g2+ (5 ml) in
100 mM Tris-HCl (pH 8.0), and LgtB (5 ml) were added to the reaction vessel to form a solution
(10 ml) as below: 10 mM UDP-Gal, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 5.0 mg of LgtB, and
5 mM compound 9; step 3: the temperature of the reaction mixture was maintained at 37°C under
20 W of microwave. Glycosyl reaction was done at 37°C for 12 h (microwave 20 W, hold 12 h at
37°C, bubble on for 5 s, off for 600 s); steps 4 and 5: UDP-Gal, M g2+ (5 ml) in 100 mM Tris-HCl
(pH 8.0), and LgtB (5 ml) were added to the reaction vessel to form a solution (10 ml) as below:
10 mM UDP-Gal, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 5.0 mg of LgtB, and 5 mM compound
9; step 3: the temperature of the reaction mixture was maintained at 37°C under 20 W of
microwave. Glycosyl reaction was done at 37°C for 12 h (microwave 20 W, hold 12 h at 37°C,
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bubble on for 5 s, off for 600 s); step 6: the resin was washed by water (10 ml) three times; the
first cycle was finished. Compound 29 was obtained after one cycle. Compound 29 was dispersed
in the 5% hydrazine aqueous solution and the reaction mixture was shaken at room temperature
for 12 h. After the reaction finished (12 h), the filtration was collected and injected to HPLC
(water/acetonitrile, 5-20, 30 min/45 min) to get compound 13 (10 mg) in yield 11.7%. 1 H-NMR
(600 M Hz, D2O), δ 8.67 (s, 1H), 7.28 (s, 1H), 4.60-4.30 (m, 8H ), 4.26-4.20 (m, 3H), 4.11 (m,
1H), 3.96-3.83 (m, 9H), 3.79-3.41 (m, 25H), 3.37-3.31 (m, 2H), 3.26-3.21 (m, 1H ), 3.16-3.12 (m,
1H), 3.08 (m, 2H), 2.83-2.70 (m, 2H), 2.41-2.36 (m, 1H), 2.26-2.20 (m, 1H), 2.07-1.86 (m, 14H),
1.33-1.28 (m, 6H), 0.92-0.86 (m, 6H). HRM S (ESI): m/z [M +3H]3+ detected: 570.5934 m/z;
calcd for C69H112N18O34 1708.7527 Da.

S cheme 14

Fully automated synthesis of compound 12 on our automated synthesizer. A synthetic program
was made for compound 11 and this program contains three enzymatic cycles (table 3.1).
Compound 9 (500 mg) was loaded into the reaction vessel and all the enzyme and sugar nucleotide
solutions were added to the corresponding tubes. The following procedures were performed by the
program on the automated synthesizer. For the first cycle, steps 1 and 2: UDP-Gal, M g2+ (5 ml) in
100 mM Tris-HCl (pH 8.0), and LgtB (5 ml) were added to the reaction vessel to form a solution
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(10 ml) as below: 10 mM UDP-Gal, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 5.0 mg of LgtB, and
5 mM compound 9; step 3: the temperature of the reaction mixture was maintained at 37°C under
20 W of microwave. Glycosyl reaction was done at 37°C for 12 h (microwave 20 W, hold 12 h at
37°C, bubble on for 5 s, off for 600 s); steps 4 and 5: UDP-Gal, M g2+ (5 ml) in 100 mM Tris-HCl
(pH 8.0), and LgtB (5 ml) were added to the reaction vessel to form a solution (10 ml) as below:
10 mM UDP-Gal, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 5.0 mg of LgtB, and 5 mM compound
9; step 6: the temperature of the reaction mixture was maintained at 37°C under 20 W of
microwave. Glycosyl reaction was done at 37°C for 12 h (microwave 20 W, hold 12 h at 37°C,
bubble on for 5 s, off for 600 s); step 7: the resin was washed by water (10 ml) three times; the
first cycle was finished. For the second cycle, steps 1 and 2: GDP-Fuc, M g2+ (5 ml) in 100 mM
Tris-HCl (pH 8.0), and 1,2-FucT (5 ml) were added to the reaction vessel to form a solution (10
ml) as below: 10 mM GDP-Fuc, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 6.5 mg of 1,2-FucT, and
5 mM compound bound resin; step 3: the temperature of the reaction mixture was maintained at
37°C under 20 W of microwave. Glycosyl reaction was done at 37°C for 12 h (microwave 20 W,
hold 12 h at 37°C, bubble on for 5 s, off for 600 s); steps 4 and 5: GDP-Fuc, M g2+ (5 ml) in 100
mM Tris-HCl (pH 8.0), and 1,2-FucT (5 ml) were added to the reaction vessel to form a solution
(10 ml) as below: 10 mM GDP-Fuc, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 6.5 mg of 1,2-FucT,
and 5 mM compound bound resin; step 6: the temperature of the reaction mixture was maintained
at 37°C under 20 W of microwave. Glycosyl reaction was done at 37°C for 12 h (microwave 20
W, hold 12 h at 37°C, bubble on for 5 s, off for 600 s); step 7: the resin was washed by water (10
ml) three times; the second cycle was finished. For the third cycle, steps 1 and 2: UDP-GalNAc,
M g2+ (5 ml) in 100 mM Tris-HCl (pH 8.0), and GtA (5 ml) were added to the reaction vessel to
form a solution (10 ml) as below: 10 mM UDP-GalNAc, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+,
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5.0 mg of GtA, and compound bound resin; step 3: the temperature of the reaction mixture was
maintained at 37°C under 20 W of microwave. Glycosyl reaction was done at 37°C for 12 h
(microwave 20 W, hold 12 h at 37°C, bubble on for 5 s, off for 600 s); steps 4 and 5: UDP-GalNAc,
M g2+ (5 ml) in 100 mM Tris-HCl (pH 8.0), and GtA (5 ml) were added to the reaction vessel to
form a solution (10 ml) as below: 10 mM UDP-GalNAc, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+,
5.0 mg of GtA, and compound bound resin; step 6: the temperature of the reaction mixture was
maintained at 37°C under 20 W of microwave. Glycosyl reaction was done at 37°C for 12 h
(microwave 20 W, hold 12 h at 37°C, bubble on for 5 s, off for 600 s); step 7: the resin was washed
by water (10 ml) three times; the third cycle was finished. Compound 11 was obtained after three
cycles. Compound 11 was dispersed in the 5% hydrazine aqueous solution and the reaction mixture
was shaken at room temperature for 12 h. After the reaction finished (12 h), the filtration was
collected and injected to HPLC (water/acetonitrile, 5-20, 30 min/45 min) to get compound 12 (10
mg) in yield 8.3%. 1 H-NM R (600 M Hz, D2O), δ 8.66 (s, 1H), 7.26 (s, 1H), 5.26 (d, J = 2.4 Hz,
1H), 5.18 (d, J = 2.4 Hz, 1H), 5.08 (m, 2H), 4.56-4.39 (m, 7H ), 4.34-4.28 (m, 2H), 4.23-4.02 (m,
12H), 3.94-3.29 (m, 47H), 3.23-3.19 (m, 1H), 3.13-3.10 (m, 1H), 3.06-3.05 (m, 2H ), 2.68-2.62
(m, 2H), 2.39-2.33 (m, 1H), 2.24-2.17 (m, 1H), 2.05-1.84 (m, 20H), 1.32-1.26 (m, 6H), 1.16-1.09
(m, 6H), 0.88-0.82 (m, 6H). HRM S (ESI): m/z [M +3H]3+ detected: 803.3528 m/z; calcd for
C97H158N18O52 2407.0273 Da.
S cheme 15
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Fully automated synthesis of compound 14 on our automated synthesizer. A synthetic program
was made for compound 30 and this program contains three cycles (table 3.1). Compound 9 (500
mg) was loaded into the reaction vessel and all the enzyme and sugar nucleotide solutions were
added to the corresponding tubes. The following procedures were performed by the program on
the automated synthesizer. For the first cycle, steps 1 and 2: UDP-Gal, M g2+ (5 ml) in 100 mM
Tris-HCl (pH 8.0), and LgtB (5 ml) were added to the reaction vessel to form a solution (10 ml)
as below: 10 mM UDP-Gal, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 5.0 mg of LgtB, and 5 mM
compound 9; step 3: the temperature of the reaction mixture was maintained at 37°C under 20 W
of microwave. Glycosyl reaction was done at 37°C for 12 h (microwave 20 W, hold 12 h at 37°C,
bubble on for 5 s, off for 600 s); steps 4 and 5: UDP-Gal, M g2+ (5 ml) in 100 mM Tris-HCl (pH
8.0), and LgtB (5 ml) were added to the reaction vessel to form a solution (10 ml) as below: 10
mM UDP-Gal, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 5.0 mg of LgtB, and 5 mM compound 9;
step 6: the temperature of the reaction mixture was maintained at 37°C under 20 W of microwave.
Glycosyl reaction was done at 37°C for 12 h (microwave 20 W, hold 12 h at 37°C, bubble on for
5 s, off for 600 s); step 7: the resin was washed by water (10 ml) three times; the first cycle was
finished. For the second cycle, steps 1 and 2: GDP-Fuc, M g2+ (5 ml) in 100 mM Tris-HCl (pH 8.0),
and 1,2-FucT (5 ml) were added to the reaction vessel to form a solution (10 ml) as below: 10 mM
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GDP-Fuc, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 6.5 mg of 1,2-FucT, and 5 mM compound
bound resin; step 3: the temperature of the reaction mixture was maintained at 37°C under 20 W
of microwave. Glycosyl reaction was done at 37°C for 12 h (microwave 20 W, hold 12 h at 37°C,
bubble on for 5 s, off for 600 s); steps 4 and 5: GDP-Fuc, M g2+ (5 ml) in 100 mM Tris-HCl (pH
8.0), and 1,2-FucT (5 ml) were added to the reaction vessel to form a solution (10 ml) as below:
10 mM GDP-Fuc, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 6.5 mg of 1,2-FucT, and 5 mM
compound bound resin; step 6: the temperature of the reaction mixture was maintained at 37°C
under 20 W of microwave. Glycosyl reaction was done at 37°C for 12 h (microwave 20 W, hold
12 h at 37°C, bubble on for 5 s, off for 600 s); step 7: the resin was washed by water (10 ml) three
times; the second cycle was finished. For the third cycle, steps 1 and 2: UDP-Gal, M g2+ (5 ml) in
100 mM Tris-HCl (pH 8.0), and GtB (5 ml) were added to the reaction vessel to form a solution
(10 ml) as below: 10 mM UDP-Gal, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 5.0 mg of GtB, and
compound bound resin; step 3: the temperature of the reaction mixture was maintained at 37°C
under 20 W of microwave. Glycosyl reaction was done at 37°C for 12 h (microwave 20 W, hold
12 h at 37°C, bubble on for 5 s, off for 600 s); steps 4 and 5: UDP-Gal, M g2+ (5 ml) in 100 mM
Tris-HCl (pH 8.0), and GtB (5 ml) were added to the reaction vessel to form a solution (10 ml) as
below: 10 mM UDP-Gal, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 5.0 mg of GtB, and compound
bound resin; step 6: the temperature of the reaction mixture was maintained at 37°C under 20 W
of microwave. Glycosyl reaction was done at 37°C for 12 h (microwave 20 W, hold 12 h at 37°C,
bubble on for 5 s, off for 600 s); step 7: the resin was washed by water (10 ml) three times; the
third cycle was finished. Compound 30 was obtained after three cycles. Compound 30 was
dispersed in the 5% hydrazine aqueous solution and the reaction mixture was shaken at room
temperature for 12 h. After the reaction finished (12 h), the filtration was collected and injected to
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HPLC (water/acetonitrile, 5-20, 30 min/45 min) to get compound 14 (8.9 mg) in yield 7.6%. 1 HNM R (600 M Hz, D2O), δ 8.66 (s, 1H), 7.26 (s, 1H), 5.23 (d, J = 2.4 Hz, 1H), 5.16-5.14 (m, 3H),
4.58-4.37 (m, 7H ), 4.34-4.28 (m, 2H), 4.24-4.02 (m, 12H), 3.94-3.74 (m, 15H), 3.72-3.54 (m,
26H), 3.47-3.29 (m, 6H), 3.23-3.19 (m, 1H), 3.14-3.10 (m, 1H), 3.07-3.06 (m, 2H ), 2.66-2.61 (m,
2H), 2.39-2.33 (m, 1H), 2.23-2.19 (m, 1H), 2.06-1.83 (m, 14H), 1.32-1.26 (m, 6H), 1.14-1.08 (m,
6H), 0.88-0.83 (m, 6H). HRM S (ESI): m/z [M +3H]3+ detected: 776.0017 m/z; calcd for
C93H152N16O52 2324.9742 Da.

S cheme 16

Fully automated synthesis of compound 15 on our automated synthesizer. A synthetic program
was made for compound 31 and this program contains three cycles (table 3.1). Compound 9 (500
mg) was loaded into the reaction vessel and all the enzyme and sugar nucleotide solutions were
added to the corresponding tubes. The following procedures were performed by the program on
the automated synthesizer. For the first cycle, steps 1 and 2: UDP-Gal, M g2+ (5 ml) in 100 mM
Tris-HCl (pH 8.0), and LgtB (5 ml) were added to the reaction vessel to form a solution (10 ml)
as below: 10 mM UDP-Gal, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 5.0 mg of LgtB, and 5 mM
compound 9; step 3: the temperature of the reaction mixture was maintained at 37°C under 20 W
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of microwave. Glycosyl reaction was done at 37°C for 12 h (microwave 20 W, hold 12 h at 37°C,
bubble on for 5 s, off for 600 s); steps 4 and 5: UDP-Gal, M g2+ (5 ml) in 100 mM Tris-HCl (pH
8.0), and LgtB (5 ml) were added to the reaction vessel to form a solution (10 ml) as below: 10
mM UDP-Gal, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 5.0 mg of LgtB, and 5 mM compound 9;
step 6: the temperature of the reaction mixture was maintained at 37°C under 20 W of microwave.
Glycosyl reaction was done at 37°C for 12 h (microwave 20 W, hold 12 h at 37°C, bubble on for
5 s, off for 600 s); step 7: the resin was washed by water (10 ml) three times; the first cycle was
finished. For the second cycle, steps 1 and 2: UDP-GlcNAc, M g2+ (5 ml) in 100 mM Tris-HCl (pH
8.0), and Lgt A (5 ml) were added to the reaction vessel to form a solution (10 ml) as below: 10
mM UDP-GlcNAc, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 5.0 mg of Lgt A, and 5 mM compound
bound resin; step 3: the temperature of the reaction mixture was maintained at 37°C under 20 W
of microwave. Glycosyl reaction was done at 37°C for 12 h (microwave 20 W, hold 12 h at 37°C,
bubble on for 5 s, off for 600 s); steps 4 and 5: UDP-GlcNAc, M g2+ (5 ml) in 100 mM Tris-HCl
(pH 8.0), and Lgt A (5 ml) were added to the reaction vessel to form a solution (10 ml) as below:
10 mM UDP-GlcNAc, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 5.0 mg of Lgt A, and 5 mM
compound bound resin; step 6: the temperature of the reaction mixture was maintained at 37°C
under 20 W of microwave. Glycosyl reaction was done at 37°C for 12 h (microwave 20 W, hold
12 h at 37°C, bubble on for 5 s, off for 600 s); step 7: the resin was washed by water (10 ml) three
times; the second cycle was finished. For the third cycle, steps 1 and 2: UDP-Gal, M g2+ (5 ml) in
100 mM Tris-HCl (pH 8.0), and LgtB (5 ml) were added to the reaction vessel to form a solution
(10 ml) as below: 10 mM UDP-Gal, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 5.0 mg of LgtB, and
compound bound resin; step 3: the temperature of the reaction mixture was maintained at 37°C
under 20 W of microwave. Glycosyl reaction was done at 37°C for 12 h (microwave 20 W, hold
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12 h at 37°C, bubble on for 5 s, off for 600 s); steps 4 and 5: UDP-Gal, M g2+ (5 ml) in 100 mM
Tris-HCl (pH 8.0), and LgtB (5 ml) were added to the reaction vessel to form a solution (10 ml)
as below: 10 mM UDP-Gal, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 5.0 mg of LgtB, and
compound bound resin; step 6: the temperature of the reaction mixture was maintained at 37°C
under 20 W of microwave. Glycosyl reaction was done at 37°C for 12 h (microwave 20 W, hold
12 h at 37°C, bubble on for 5 s, off for 600 s); step 7: the resin was washed by water (10 ml) three
times; the third cycle was finished. Compound 31 was obtained after three cycles. Compound 31
was dispersed in the 5% hydrazine aqueous solution and the reaction mixture was shaken at room
temperature for 12 h. After the reaction finished (12 h), the filtration was collected and injected to
HPLC (water/acetonitrile, 5-20, 30 min/45 min) to get compound 15 (9.5 mg) in yield 9.2%. 1 HNM R (600 M Hz, D2O), δ 8.66 (s, 1H), 7.26 (s, 1H), 4.50-4.28 (m, 10H ), 4.23-4.17 (m, 3H), 4.094.06 (m, 2H), 3.94-3.80 (m, 10H), 3.76-3.38 (m, 35H), 3.36-3.27 (m, 2H), 3.23-3.19 (m, 1H),
3.14-3.10 (m, 1H), 3.06-3.04 (m, 2H ), 2.71-2.63 (m, 2H), 2.39-2.33 (m, 1H), 2.24-2.17 (m, 1H),
2.06-1.81 (m, 17H), 1.31-1.26 (m, 6H), 0.89-0.84 (m, 6H). HRM S (ESI): m/z [M +3H]3+ detected:
692.3038 m/z; calcd for C83H135N17O44 2073.8849 Da.

S cheme 17

Fully automated synthesis of M ucin 1 peptide (compound 16) on our automated synthesizer. A
synthetic program was made for compound 32 and this program contains ten cycles (table S1).
Compound 8 (500 mg) was loaded into the reaction vessel and all the amino acid, base and
activator solutions were added to the corresponding tubes. The following procedures were
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performed by the program on the automated synthesizer. For the first cycle, step 1: deprotection
solution (20% piperidine in DM F solution, 3 ml) was added to the reaction vessel; step 2: the
temperature of the reaction mixture was maintained at 50°C under 25 W of microwave. Reaction
was done at 50°C for 3 min (microwave 25 W, hold 3 min at 50°C, bubble on for 2 s, off for 3 s,
drain 100 s); Step 3: deprotection solution (20% piperidine in DM F solution, 3 ml) was added to
the reaction vessel; step 4: the temperature of the reaction mixture was maintained at 50°C under
25 W of microwave. Reaction was done at 50°C for 3 min (microwave 25 W, hold 3 min at 50°C,
bubble on for 2 s, off for 3 s, drain 100 s); step 5: the resin was washed by DM F (10 ml) three
times; step 6: Fmoc-Pro-OH (2.5 ml, 0.2 M ), HATU (1 ml, 0.5 M ) and DIEA (1 ml, 0.5 M ) were
added to the reaction vessel; step 7: the temperature of the reaction mixture was maintained at
50°C under 25 W of microwave. Reaction was done at 50°C for 10 min (microwave 25 W, hold
10 min at 50°C, bubble on for 2 s, off for 3 s, drain 100 s); step 8: Fmoc-Pro-OH (2.5 ml, 0.2 M),
HATU (1 ml, 0.5 M ) and DIEA (1 ml, 0.5 M ) were added to the reaction vessel; step 9: the
temperature of the reaction mixture was maintained at 50°C under 25 W of microwave. Reaction
was done at 50°C for 10 min (microwave 25 W, hold 10 min at 50°C, bubble on for 2 s, off for 3
s, drain 100 s); step 10: the resin was washed by DM F (10 ml) three times; the first cycle was
finished. For the second and third cycles, the synthesizer performed the same steps as the first
cycle (the corresponding amino acid was injected following the program). For the fourth cycle
(sugar amino acid cycle), step 1: deprotection solution (20% piperidine in DM F solution, 3 ml)
was added to the reaction vessel; step 2: the temperature of the reaction mixture was maintained
at 50°C under 25 W of microwave. Reaction was done at 50°C for 3 min (microwave 25 W, hold
3 min at 50°C, bubble on for 2 s, off for 3 s, drain 100 s); Step 3: deprotection solution (20%
piperidine in DM F solution, 3 ml) was added to the reaction vessel; step 4: the temperature of the
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reaction mixture was maintained at 50°C under 25 W of microwave. Reaction was done at 50°C
for 3 min (microwave 25 W, hold 3 min at 50°C, bubble on for 2 s, off for 3 s, drain 100 s); step
5: the resin was washed by DM F (10 ml) three times; step 6: Fmoc-Ser(Core 3)-OH (2.5 ml, 0.2
M ), HATU (1 ml, 0.5 M ) and DIEA (1 ml, 0.5 M ) were added to the reaction vessel; step 7: the
temperature of the reaction mixture was maintained at 50°C under 25 W of microwave. Reaction
was done at 50°C for 1 h (microwave 25 W, hold 10 min at 50°C, bubble on for 2 s, off for 3 s,
drain 100 s); step 8: Fmoc- Ser(Core 3)-OH (2.5 ml, 0.2 M ), HATU (1 ml, 0.5 M ) and DIEA (1
ml, 0.5 M ) were added to the reaction vessel; step 9: the temperature of the reaction mixture was
maintained at 50°C under 25 W of microwave. Reaction was done at 50°C for 1 h (microwave 25
W, hold 10 min at 50°C, bubble on for 2 s, off for 3 s, drain 100 s); step 10: the resin was washed
by DM F (10 ml) three times; the fourth cycle was finished. For the 5th to 9th cycles, the synthesizer
performed the same steps as the first cycle (the corresponding amino acid was injected following
the program). For the 10th cycle, step 1: deprotection solution (20% piperidine in DM F solution,
3 ml) was added to the reaction vessel; step 2: the temperature of the reaction mixture was
maintained at 50°C under 25 W of microwave. Reaction was done at 50°C for 3 min (microwave
25 W, hold 3 min at 50°C, bubble on for 2 s, off for 3 s, drain 100 s); Step 3: deprotection solution
(20% piperidine in DM F solution, 3 ml) was added to the reaction vessel; step 4: the temperature
of the reaction mixture was maintained at 50°C under 25 W of microwave. Reaction was done at
50°C for 3 min (microwave 25 W, hold 3 min at 50°C, bubble on for 2 s, off for 3 s, drain 100 s);
step 5: the resin was washed by DMF (10 ml) three times; step 6: cocktail (TFA:water:TIS:DODT
= 92.5:2.5:2.5:2.5; 10 ml) was added to the reaction vessel; step 7: the temperature of the reaction
mixture was maintained at room temperature without microwave. Reaction was done at room
temperature for 3 h (microwave 0 W, hold 3 h at room temperature, bubble on for 2 s, off for 3 s,
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drain 100 s); step 8: the resin was washed by DM F (10 ml) three times; the 10th cycle was finished.
Compound 32 was obtained after 10 cycles. Compound 32 was dispersed in the 5% hydrazine
aqueous solution and the reaction mixture was shaken at room temperature for 12 h. After the
reaction finished (12 h), the filtration was collected and injected to HPLC (water/acetonitrile, 520, 30 min/45 min) to get compound 16 (1.1 mg) in yield 18.9%. 1 H-NM R (600 M Hz, D2O), δ
8.64 (s, 1H), 7.26 (s, 1H), 4.63-4.60 (m, 1H), 4.59-4.58 (m, 1H), 4.56-4.54 (m, 1H), 4.48-4.45 (m,
2H), 4.40-4.38 (m, 1H ), 4.32-4.27 (m, 2H), 4.23-4.19 (m, 1H), 4.16-4.09 (m, 3H), 3.91-3.86 (m,
4H), 3.83-3.81 (m, 1H), 3.76-3.54 (m, 10H), 3.46-3.41 (m, 3H), 3.37-3.27 (m, 4H), 3.22-3.19 (m,
1H ), 3.13-3.09 (m, 1H), 3.06-3.04 (m, 2H), 2.87-2.77 (m, 2H), 2.38-2.32 (m, 1H), 2.22-2.17 (m,
1H), 2.03-1.81 (m, 14H), 1.28-1.26 (m, 6H), 0.88-0.83 (m, 6H). HRM S (ESI): m/z [M +3H]3+
detected: 462.5574 m/z; calcd for C57H92N16O24 1384.6470 Da.

S cheme 18

Fully automated synthesis of compound 17 on our automated synthesizer. A synthetic program
was made for compound 33 and this program contains one cycle (table 3.1). Compound 32 (500
mg) was loaded into the reaction vessel and all the enzyme and sugar nucleotide solutions were
added to the corresponding tubes. The following procedures were performed by the program on
the automated synthesizer. For the first cycle, steps 1 and 2: UDP-Gal, M g2+ (5 ml) in 100 mM
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Tris-HCl (pH 8.0), and LgtB (5 ml) were added to the reaction vessel to form a solution (10 ml)
as below: 10 mM UDP-Gal, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 5.0 mg of LgtB, and 5 mM
compound 32; step 3: the temperature of the reaction mixture was maintained at 37°C under 20 W
of microwave. Glycosyl reaction was done at 37°C for 12 h (microwave 20 W, hold 12 h at 37°C,
bubble on for 5 s, off for 600 s); steps 4 and 5: UDP-Gal, M g2+ (5 ml) in 100 mM Tris-HCl (pH
8.0), and LgtB (5 ml) were added to the reaction vessel to form a solution (10 ml) as below: 10
mM UDP-Gal, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 5.0 mg of LgtB, and 5 mM compound 32;
step 3: the temperature of the reaction mixture was maintained at 37°C under 20 W of microwave.
Glycosyl reaction was done at 37°C for 12 h (microwave 20 W, hold 12 h at 37°C, bubble on for
5 s, off for 600 s); step 6: the resin was washed by water (10 ml) three times; the first cycle was
finished. Compound 33 was obtained after one cycle. Compound 33 was dispersed in the 5%
hydrazine aqueous solution and the reaction mixture was shaken at room temperature for 12 h.
After the reaction finished (12 h), the filtration was collected and injected to HPLC
(water/acetonitrile, 5-20, 30 min/45 min) to get compound 17 (10.2 mg) in yield 13.2%. 1 H-NMR
(600 M Hz, D2O), δ 8.67 (s, 1H), 7.27 (s, 1H), 4.64-4.56 (m, 4H), 4.53-4.47 (m, 2H), 4.43-4.39 (m,
2H ), 4.36-4.29 (m, 2H), 4.26-4.12 (m, 1H), 4.18-4.11 (m, 3H), 3.94-3.83 (m, 7H), 3.78-3.58 (m,
15H), 3.47-3.42 (m, 4H), 3.38-3.29 (m, 2H), 3.26-3.21 (m, 1H ), 3.16-3.11 (m, 1H), 3.08-3.07 (m,
2H), 2.89-2.77 (m, 2H), 2.41-2.35 (m, 1H), 2.26-2.20 (m, 1H), 2.06-1.82 (m, 14H), 1.32-1.28 (m,
6H), 0.90-0.86 (m, 6H). HRM S (ESI): m/z [M +3H]3+ detected: 516.5756 m/z; calcd for
C63H102N16O29 1546.6999 Da.

S cheme 19
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Fully automated synthesis of compound 18 on our automated synthesizer. A synthetic program
was made for compound 34 and this program contains three cycles (table S1). Compound 32 (500
mg) was loaded into the reaction vessel and all the enzyme and sugar nucleotide solutions were
added to the corresponding tubes. The following procedures were performed by the program on
the automated synthesizer. For the first cycle, steps 1 and 2: UDP-Gal, M g2+ (5 ml) in 100 mM
Tris-HCl (pH 8.0), and LgtB (5 ml) were added to the reaction vessel to form a solution (10 ml)
as below: 10 mM UDP-Gal, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 5.0 mg of LgtB, and 5 mM
compound 32; step 3: the temperature of the reaction mixture was maintained at 37°C under 20 W
of microwave. Glycosyl reaction was done at 37°C for 12 h (microwave 20 W, hold 12 h at 37°C,
bubble on for 5 s, off for 600 s); steps 4 and 5: UDP-Gal, M g2+ (5 ml) in 100 mM Tris-HCl (pH
8.0), and LgtB (5 ml) were added to the reaction vessel to form a solution (10 ml) as below: 10
mM UDP-Gal, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 5.0 mg of LgtB, and 5 mM compound 32;
step 6: the temperature of the reaction mixture was maintained at 37°C under 20 W of microwave.
Glycosyl reaction was done at 37°C for 12 h (microwave 20 W, hold 12 h at 37°C, bubble on for
5 s, off for 600 s); step 7: the resin was washed by water (10 ml) three times; the first cycle was
finished. For the second cycle, steps 1 and 2: GDP-Fuc, M g2+ (5 ml) in 100 mM Tris-HCl (pH 8.0),
and 1,2-FucT (5 ml) were added to the reaction vessel to form a solution (10 ml) as below: 10 mM
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GDP-Fuc, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 6.5 mg of 1,2-FucT, and 5 mM compound
bound resin; step 3: the temperature of the reaction mixture was maintained at 37°C under 20 W
of microwave. Glycosyl reaction was done at 37°C for 12 h (microwave 20 W, hold 12 h at 37°C,
bubble on for 5 s, off for 600 s); steps 4 and 5: GDP-Fuc, M g2+ (5 ml) in 100 mM Tris-HCl (pH
8.0), and 1,2-FucT (5 ml) were added to the reaction vessel to form a solution (10 ml) as below:
10 mM GDP-Fuc, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 6.5 mg of 1,2-FucT, and 5 mM
compound bound resin; step 6: the temperature of the reaction mixture was maintained at 37°C
under 20 W of microwave. Glycosyl reaction was done at 37°C for 12 h (microwave 20 W, hold
12 h at 37°C, bubble on for 5 s, off for 600 s); step 7: the resin was washed by water (10 ml) three
times; the second cycle was finished. For the third cycle, steps 1 and 2: UDP-GalNAc, M g2+ (5 ml)
in 100 mM Tris-HCl (pH 8.0), and GtA (5 ml) were added to the reaction vessel to form a solution
(10 ml) as below: 10 mM UDP-GalNAc, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 5.0 mg of GtA,
and compound bound resin; step 3: the temperature of the reaction mixture was maintained at 37°C
under 20 W of microwave. Glycosyl reaction was done at 37°C for 12 h (microwave 20 W, hold
12 h at 37°C, bubble on for 5 s, off for 600 s); steps 4 and 5: UDP-GalNAc, M g2+ (5 ml) in 100
mM Tris-HCl (pH 8.0), and GtA (5 ml) were added to the reaction vessel to form a solution (10
ml) as below: 10 mM UDP-GalNAc, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 5.0 mg of GtA, and
compound bound resin; step 6: the temperature of the reaction mixture was maintained at 37°C
under 20 W of microwave. Glycosyl reaction was done at 37°C for 12 h (microwave 20 W, hold
12 h at 37°C, bubble on for 5 s, off for 600 s); step 7: the resin was washed by water (10 ml) three
times; the third cycle was finished. Compound 34 was obtained after three cycles. Compound 34
was dispersed in the 5% hydrazine aqueous solution and the reaction mixture was shaken at room
temperature for 12 h. After the reaction finished (12 h), the filtration was collected and injected to
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HPLC (water/acetonitrile, 5-20, 30 min/45 min) to get compound 18 (9.7 mg) in yield 10.2%. 1 HNM R (600 M Hz, D2O), δ 8.66 (s, 1H), 7.26 (s, 1H), 5.26 (d, J = 2.4 Hz, 1H), 5.08 (d, J = 2.8 Hz,
1H), 4.60-4.37 (m, 5H), 4.33-4.27 (m, 2H), 4.23-4.22 (m, 2H), 4.16-4.09 (m, 6H), 3.91-3.56 (m,
29H), 3.47-3.27 (m, 5H), 3.23-3.19 (m, 1H ), 3.13-3.10 (m, 1H), 3.06-3.04 (m, 2H), 2.83-2.69 (m,
2H), 2.37-2.33 (m, 1H), 2.22-2.18 (m, 1H), 2.05-1.82 (m, 17H), 1.32-1.26 (m, 6H), 1.16 (d, J =
4.4 Hz, 3H), 0.88-0.84 (m, 6H). HRM S (ESI): m/z [M +3H]3+ detected: 632.9555 m/z; calcd for
C77H125N17O38 1895.8371 Da.

S cheme 20

Fully automated synthesis of compound 19 on our automated synthesizer. A synthetic program
was made for compound 35 and this program contains three cycles (table 3.1). Compound 32 (500
mg) was loaded into the reaction vessel and all the enzyme and sugar nucleotide solutions were
added to the corresponding tubes. The following procedures were performed by the p rogram on
the automated synthesizer. For the first cycle, steps 1 and 2: UDP-Gal, M g2+ (5 ml) in 100 mM
Tris-HCl (pH 8.0), and LgtB (5 ml) were added to the reaction vessel to form a solution (10 ml)
as below: 10 mM UDP-Gal, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 5.0 mg of LgtB, and 5 mM
compound 32; step 3: the temperature of the reaction mixture was maintained at 37°C under 20 W
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of microwave. Glycosyl reaction was done at 37°C for 12 h (microwave 20 W, hold 12 h at 37°C,
bubble on for 5 s, off for 600 s); steps 4 and 5: UDP-Gal, M g2+ (5 ml) in 100 mM Tris-HCl (pH
8.0), and LgtB (5 ml) were added to the reaction vessel to form a solution (10 ml) as below: 10
mM UDP-Gal, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 5.0 mg of LgtB, and 5 mM compound 32;
step 6: the temperature of the reaction mixture was maintained at 37°C under 20 W of microwave.
Glycosyl reaction was done at 37°C for 12 h (microwave 20 W, hold 12 h at 37°C, bubble on for
5 s, off for 600 s); step 7: the resin was washed by water (10 ml) three times; the first cycle was
finished. For the second cycle, steps 1 and 2: GDP-Fuc, M g2+ (5 ml) in 100 mM Tris-HCl (pH 8.0),
and 1,2-FucT (5 ml) were added to the reaction vessel to form a solution (10 ml) as below: 10 mM
GDP-Fuc, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 6.5 mg of 1,2-FucT, and 5 mM compound
bound resin; step 3: the temperature of the reaction mixture was maintained at 37°C under 20 W
of microwave. Glycosyl reaction was done at 37°C for 12 h (microwave 20 W, hold 12 h at 37°C,
bubble on for 5 s, off for 600 s); steps 4 and 5: GDP-Fuc, M g2+ (5 ml) in 100 mM Tris-HCl (pH
8.0), and 1,2-FucT (5 ml) were added to the reaction vessel to form a solution (10 ml) as below:
10 mM GDP-Fuc, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 6.5 mg of 1,2-FucT, and 5 mM
compound bound resin; step 6: the temperature of the reaction mixture was maintained at 37°C
under 20 W of microwave. Glycosyl reaction was done at 37°C for 12 h (microwave 20 W, hold
12 h at 37°C, bubble on for 5 s, off for 600 s); step 7: the resin was washed by water (10 ml) three
times; the second cycle was finished. For the third cycle, steps 1 and 2: UDP-Gal, M g2+ (5 ml) in
100 mM Tris-HCl (pH 8.0), and GtB (5 ml) were added to the reaction vessel to form a solution
(10 ml) as below: 10 mM UDP-Gal, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 5.0 mg of GtB, and
compound bound resin; step 3: the temperature of the reaction mixture was maintained at 37°C
under 20 W of microwave. Glycosyl reaction was done at 37°C for 12 h (microwave 20 W, hold
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12 h at 37°C, bubble on for 5 s, off for 600 s); steps 4 and 5: UDP-Gal, M g2+ (5 ml) in 100 mM
Tris-HCl (pH 8.0), and GtB (5 ml) were added to the reaction vessel to form a solution (10 ml) as
below: 10 mM UDP-Gal, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 5.0 mg of GtB, and compound
bound resin; step 6: the temperature of the reaction mixture was maintained at 37°C under 20 W
of microwave. Glycosyl reaction was done at 37°C for 12 h (microwave 20 W, hold 12 h at 37°C,
bubble on for 5 s, off for 600 s); step 7: the resin was washed by water (10 ml) three times; the
third cycle was finished. Compound 35 was obtained after three cycles. Compound 35 was
dispersed in the 5% hydrazine aqueous solution and the reaction mixture was shaken at room
temperature for 12 h. After the reaction finished (12 h), the filtration was collected and injected to
HPLC (water/acetonitrile, 5-20, 30 min/45 min) to get compound 19 (9.3 mg) in yield 10%. 1 HNM R (600 M Hz, D2O), δ 8.66 (s, 1H), 7.26 (s, 1H), 5.24 (d, J = 2.4 Hz, 1H), 5.14 (m, 1H), 4.634.46 (m, 4H), 4.40-4.38 (m, 2H), 4.34-4.27 (m, 2H), 4.23-4.09 (m, 7H), 3.91-3.56 (m, 30H), 3.463.27 (m, 5H), 3.22-3.19 (m, 1H ), 3.13-3.09 (m, 1H), 3.06-3.04 (m, 2H), 2.76-2.66 (m, 2H), 2.382.33 (m, 1H), 2.22-2.19 (m, 1H), 2.04-1.82 (m, 14H), 1.31-1.26 (m, 6H), 1.16 (d, J = 4.4 Hz, 3H),
0.88-0.84 (m, 6H). HRM S (ESI): m/z [M +3H]3+ detected: 619.2802 m/z; calcd for
C75H122N16O38 1854.8106 Da.

S cheme 21
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Fully automated synthesis of compound 20 on our automated synthesizer. A synthetic program
was made for compound 36 and this program contains three cycles (table 3.1). Compound 32 (500
mg) was loaded into the reaction vessel and all the enzyme and sugar nucleotide solutions were
added to the corresponding tubes. The following procedures were performed by the program on
the automated synthesizer. For the first cycle, steps 1 and 2: UDP-Gal, M g2+ (5 ml) in 100 mM
Tris-HCl (pH 8.0), and LgtB (5 ml) were added to the reaction vessel to form a solution (10 ml)
as below: 10 mM UDP-Gal, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 5.0 mg of LgtB, and 5 mM
compound 32; step 3: the temperature of the reaction mixture was maintained at 37°C under 20 W
of microwave. Glycosyl reaction was done at 37°C for 12 h (microwave 20 W, hold 12 h at 37°C,
bubble on for 5 s, off for 600 s); steps 4 and 5: UDP-Gal, M g2+ (5 ml) in 100 mM Tris-HCl (pH
8.0), and LgtB (5 ml) were added to the reaction vessel to form a solution (10 ml) as below: 10
mM UDP-Gal, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 5.0 mg of LgtB, and 5 mM compound 32;
step 6: the temperature of the reaction mixture was maintained at 37°C under 20 W of microwave.
Glycosyl reaction was done at 37°C for 12 h (microwave 20 W, hold 12 h at 37°C, bubble on for
5 s, off for 600 s); step 7: the resin was washed by water (10 ml) three times; the first cycle was
finished. For the second cycle, steps 1 and 2: UDP-GlcNAc, M g2+ (5 ml) in 100 mM Tris-HCl (pH
8.0), and Lgt A (5 ml) were added to the reaction vessel to form a solution (10 ml) as below: 10

87

mM UDP-GlcNAc, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 5.0 mg of Lgt A, and 5 mM compound
bound resin; step 3: the temperature of the reaction mixture was maintained at 37°C under 20 W
of microwave. Glycosyl reaction was done at 37°C for 12 h (microwave 20 W, hold 12 h at 37°C,
bubble on for 5 s, off for 600 s); steps 4 and 5: UDP-GlcNAc, M g2+ (5 ml) in 100 mM Tris-HCl
(pH 8.0), and Lgt A (5 ml) were added to the reaction vessel to form a solution (10 ml) as below:
10 mM UDP-GlcNAc, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 5.0 mg of Lgt A, and 5 mM
compound bound resin; step 6: the temperature of the reaction mixture was maintained at 37°C
under 20 W of microwave. Glycosyl reaction was done at 37°C for 12 h (microwave 20 W, hold
12 h at 37°C, bubble on for 5 s, off for 600 s); step 7: the resin was washed by water (10 ml) three
times; the second cycle was finished. For the third cycle, steps 1 and 2: UDP-Gal, M g2+ (5 ml) in
100 mM Tris-HCl (pH 8.0), and LgtB (5 ml) were added to the reaction vessel to form a solution
(10 ml) as below: 10 mM UDP-Gal, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 5.0 mg of LgtB, and
compound bound resin; step 3: the temperature of the reaction mixture was maintained at 37°C
under 20 W of microwave. Glycosyl reaction was done at 37°C for 12 h (microwave 20 W, hold
12 h at 37°C, bubble on for 5 s, off for 600 s); steps 4 and 5: UDP-Gal, M g2+ (5 ml) in 100 mM
Tris-HCl (pH 8.0), and LgtB (5 ml) were added to the reaction vessel to form a solution (10 ml)
as below: 10 mM UDP-Gal, 50 mM Tris-HCl (pH 8.0), 5 mM M g2+, 5.0 mg of LgtB, and
compound bound resin; step 6: the temperature of the reaction mixture was maintained at 37°C
under 20 W of microwave. Glycosyl reaction was done at 37°C for 12 h (microwave 20 W, hold
12 h at 37°C, bubble on for 5 s, off for 600 s); step 7: the resin was washed by water (10 ml) three
times; the third cycle was finished. Compound 36 was obtained after three cycles. Compound 36
was dispersed in the 5% hydrazine aqueous solution and the reaction mixture was shaken at room
temperature for 12 h. After the reaction finished (12 h), the filtration was collected and injected to
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HPLC (water/acetonitrile, 5-20, 30 min/45 min) to get compound 20 (10.2 mg) in yield 10.7%.
1

H-NM R (600 M Hz, D2O), δ 8.66 (s, 1H), 7.26 (s, 1H), 4.63-4.59 (m, 5H), 4.56-4.45 (m, 2H),

4.40-4.06 (m, 9H), 3.92-3.56 (m, 30H), 3.49-3.40 (m, 6H), 3.36-3.27 (m, 2H), 3.23-3.19 (m, 1H ),
3.13-3.09 (m, 1H), 3.06-3.04 (m, 2H), 2.86-2.73 (m, 2H), 2.39-2.33 (m, 1H), 2.24-2.18 (m, 1H),
2.04-1.80 (m, 17H), 1.30-1.26 (m, 6H), 0.88-0.84 (m, 6H). HRM S (ESI): m/z [M +3H]3+ detected:
638.2873 m/z; calcd for C77H125N17O39 1911.8321 Da.
3.8

Conclusion

In summary, a fully machine-driven system based on the use of two peptide synthesizers has been
developed for the automated synthesis of glycopeptides. The standardized process has five steps:
automated synthesis of peptide backbone, resin transfer, automated synthesis of oligosaccharide
portion, compound release and purification. A peptide (piece of M ucin 1) decorated with several
important oligosaccharide epitopes was selected and successfully prepared in an automated
manner. The use of a functionalized silica gel resin overcomes the limitations of traditional solid
supports for enzymatic synthesis. It allows the formation of peptide bonds chemically and
glycosidic bonds enzymatically on a single solid phase support.
This study represents a proof-of-concept demonstration that a two-solution system for the
synthesis of glycopeptides can be achieved in an automated manner using two commercially
available peptide synthesizers. This work will enable an improved, combined instrument for
automated glycopeptide synthesis in the future. Such improvements should include more storage
tubes for both organic reagents and reagents of enzymatic glycosylation, a temperature control
system for enzyme storage, a detection system for monitoring reaction processes, and more wash
bottles for organic solvents and water buffers.
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APPENDICES
Appendix A NMR S PECTRUMS OF COMPOUNDS IN PART TWO
1H-NMR spectrum of PNIPAM and Lac-PNIPAM in MeOD-d4 at 300K
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94
NMR spectrum of compound 13 in MeOD-d4 at 300K
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96
NMR spectrum of compound 14 in MeOD-d4 at 300K
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98
NMR spectrum of compound 15 in MeOD-d4 at 300K

99
NMR spectrum of compound 17 in D2O at 300K
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101
NMR spectrum of compound 18 in D2O at 300K

102

103
NMR spectrum of compound 19 in D2O at 300K
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105
NMR spectrum of compound 22 in D2O at 300K
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107
NMR spectrum of compound 23 in D2O at 300K
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109
NMR spectrum of compound 24 in D2O at 300K
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111
NMR spectrum of compound 25 in D2O at 300K

112

113
NMR spectrum of compound 6 in D2O at 300K
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115
NMR spectrum of compound 7 in D2O at 300K

116
NMR spectrum of compound 8 in D2O at 300K
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118
NMR spectrum of compound 9 in D2O at 300K
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120
NMR spectrum of compound 10 in D2O at 300K
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Appendix B NMR S PECTRUMS OF COMPOUNDS IN PART THREE
NMR spectrum of lewis X antigen in D2O at 300K
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NMR spectrum of lewis X antigen in D2O at 300K

123
600 MHz 1H-NMR spectrum of Compound 10 in D2O at 300K

124
600 MHz 1H-NMR spectrum of Compound 13 in D2O at 300K

125
600 MHz 1H-NMR spectrum of Compound 12 in D2O at 300K

126
600 MHz 1H-NMR spectrum of Compound 14 in D2O at 300K

127
600 MHz 1H-NMR spectrum of Compound 15 in D2O at 300K

128
600 MHz 1H-NMR spectrum of Compound 16 in D2O at 300K

129
600 MHz 1H-NMR spectrum of Compound 17 in D2O at 300K

130
600 MHz 1H-NMR spectrum of Compound 18 in D2O at 300K

131
600 MHz 1H-NMR spectrum of Compound 19 in D2O at 300K

132
600 MHz 1H-NMR spectrum of Compound 20 in D2O at 300K
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Appendix C MAS S S PECTRUMS AND CHROMATOGRAM OF COMPOUNDS IN
PART THREE
HPLC and Mass spectrum of Compound 10
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HPLC and Mass spectrum of Compound 13
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mV
1500 Detector A 210nm

psi
Pump A Pressure
Pump B Pressure
1750

1250

1500

1000

1250

750

1000
500
750
250
500
0
250
-250
0
0.0

2.5

5.0

7.5

10.0

12.5

15.0

[M+3H]

17.5

20.0

22.5

25.0

27.5

min

135
HPLC and Mass spectrum of Compound 12
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HPLC and Mass spectrum of Compound 14
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HPLC and Mass spectrum of Compound 15
Datafile Name:Core2-LacNAc.lcd
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HPLC and Mass spectrum of Compound 16
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HPLC and Mass spectrum of Compound 17
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HPLC and Mass spectrum of Compound 18
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HPLC and Mass spectrum of Compound 19
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HPLC and Mass spectrum of Compound 20
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